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Fluorogenic Derivatization of Pro-Quinoidal Species:  
 
From Biogenic Amines to Protein Bound 3-Nitrotyrosine 
 
 
The focuses of this dissertation are an examination and advancement of chemistries for the 
fluorogenic derivatization of the analysis of proquiniodal species. The term proquinoidal species 
specifically refers to a group of biologically active compounds that easily may be oxidized to the 
corresponding quinones or imino-quinones.  Catechols (Cs), catecholamines (CAs), and 5-hydroxyindoles 
(5-HIs) are classes of biogenic amines that affect neuroregulatory functions such as mood and appetite.  
While the determination of these classes of substances has been the accomplished by a variety of 
techniques over the past several decades, a recent approach has been their conversation to a 
fluorescent product by use of the fluorogenic reagents benzylamime (BA) or diphenylethylenediamine 
(DPE).    
In the first section of this work, a critical examination of these derivatization chemistries is 
undertaken through product isolation, derivatization kinetics investigations, and yield determination for 
three substances that represent each analyte class.  While not investigated in detail, it is recognized that 
3-nitrotyrosine residues in peptides and proteins (a post-translational modification that has been 
associated with various age related pathologies such as atherosclerosis, neuropathies and others 
conditions), when reduced to the corresponding 3-aminotyrosine residues, undergo an analogous 
derivatization reaction to the catechol class.  Application of the described derivatization reaction to such 
substances is an obvious and valuable extension of the present findings.  Results obtained from the 
initial finding indicated that improvements regarding the physical-chemical properties of the DPE and/or 
BA regents would be highly useful in future applications directed toward the analysis of 3-nitrotyrosine 
residues, particularly as regards solubility and selective isolation of the formed product.    
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The approach described herein relies on the reduction of the 3-NY residue to the corresponding 
3-aminotyrosine (3-AY), with subsequent derivatization by either BA or DPE. Enhancement of the 
existing derivatization reagents is explored through chemical modification of the reagents through the 
attachment of various substituents for the purpose of enhanced isolation and/or detection, increasing 
reagent aqueous solubility, maximization of single production formation, and allowing for the 
incorporation of stable isotopes.  Recognizing that samples of biological origin are present as a complex 
mixture, further to the alluded to selectivity achieved via reagent design, significant improvements of 
chromatographic peak capacity were additionally sought.  Efforts toward this goal included the 
fabrication of an Extreme Ultra-Pressure Liquid Chromatography (XUPLC) system, which utilized long 
columns packed with sub-2µm particles (75 µm id x 0.5-2.0 m L; packed with 1.9 µm BEH C18 particles) 
necessitating operation at 30,000 psi. 
An overall goal was the integration of the results obtained from these two differing but 
complimentary research areas.  The derivatization investigations revealed the derivatization reactions to 
be complete with 2 hours, with yields for Cs of no less than 70% when either reagent, BA or DPE, was 
utilized.  Further reagent design and evaluation efforts were directed toward the characterization of BA 
and DPE that was elaborated to possess a sulfonic acid moiety, which provided for enhanced aqueous 
solubility and a selective sample preparation handle via strong anion exchange solid phase extraction.  
An alternate approach was the elaboration of each base regent to the dimethylamino-analog, again with 
the motivation being enhanced aqueous solubility but now potentially better electrospray ionization 
properties for mass spectrometry.  Efforts in the XUPLC area revealed the expected gain in resolution 
and concurrent increased peak capacity.  In summary, this dissertation describes advances in the 
utilization of existing reagents, the preparation and characterization of new reagent analogs and 
describes an advanced chromatographic system.  All of these aspects are expected to be of high valuable 
x 
 
in the analytical chemistry of catechol determinations and the related area of 3-nitrotyrosine residues 
present in peptides and proteins. 
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Chapter 1 
Introduction  
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1.3 Introduction 
 
The following body of work describes the development of methodologies, which aim at 
enhancing the analysis of proquinoidal compounds. Proquinoidal compounds, which are elaborated in 
greater detail in the following sections and in chapter 2, refer to any compound which can be oxidized to 
a corresponding quinoid or iminoquinoid. The oxidized form represents a highly reactive electrophilic 
species that is amenable to further reactions that eventually result in a product of enhanced analytical 
detectability. This introduction provides an overview and brief highlights of the rational for which 
analytes are examined in subsequent chapters along with the biological importance of those analytes. 
While numerous detection methods have been used for the detection of proquinoidal substances, the 
following body of work details current efforts in the refinement of usage of current reagents and the 
development of newer reagents for the derivatization of these substances, with fluorescence and mass 
spectrometry being targeted as the primary means of detection. 
 
Analytes of Interest  
 
Catechols, Catecholamines, and 5-Hydroxindoles 
 
Catechols, catecholamines, and 5-hydroxyindoles are an important series of biological 
compounds which are related in both the way they are endogenously synthesized and in the 
bioregulatory roles they perform[1]. Perhaps the most extensively studied within these classes of 
compounds is dopamine[2], a catecholamine which affects the mood and appetite[3]. Regulation of 
dopamine levels within the brain also has implications for disease states such as schizophrenia and 
Parkinson’s disease [4]. The well-established route for endogenously synthesized DA begins with tyrosine, 
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which is hydroxylated at the 3 position by tyrosine hydroxylase to form l-3,4-dihydroxyphenylalanine (L-
DOPA)[5]. L-DOPA, itself a catecholamine, can then be decarboxylated by DOPA decarboxylase to 
dopamine[6]. Oxidation of dopamine by dopamine β-hydroxylase creates norepinephrine, a potent 
catecholamine which acts as a hormone for stress and memory[7]. NE can be further modified by 
phenylethanolamine metyltransferase to epinephrine, a similar hormone responsible for regulating 
heart rate and the fight-or-flight response[8]. 
Serotonin (5-HT) is another biogenic amine responsible for behavior and sleep[9]. Similar to how 
catecholamine synthesis begins with an amino acid, the series of biologically relevant 5-hydroxyindoles 
begins with tryptophan. Although most 5-HT synthesis occurs within the gut, synthesis in the brain 
begins within serotonergic neurons via hydroxylation of tryptophan at the 5 position by tryptophan 
hydroxylase creating 5-hydroxytryptophan (5-HTP) [10]. 5-HTP is subsequently acted upon by 5-HTP 
decarboxylase, producing 5-HT[11]. 5-HT can be metabolized through two distinct pathways. 
Arylalkylamine N-acetyltransferase can acetylate the primary amine on serotonin, producing N-acetyl-
serotonin[12]. Monoamine oxidases are also capable of degrading 5-HT by oxidation of the primary amine 
to create 5-hydroxyindoleacetic acid (5-HIAA)[13]. 
Not only are these catechols, catecholamines, and 5-hydroxyindoles all biologically significant, 
they also share a high degree of structural similarity and fall into the description of proquinoidal 
substances.  As these compounds share similar roles in bioregulation, they can all be found within a 
commonly analyzed compartment for neuroregulation, the cerebrospinal fluid [14]. Although this is not a 
comprehensive list of mood altering endogenous small molecules found within the brain, it should serve 
to highlight the degree of complexity one may encounter during analysis of relevant matrices. As such, 
comprehensive separation, proper identification, and accurate quantitative measurements are crucial 
for clinical evaluation of relevant disease states. These classes of proquinoidal compounds will be 
further elaborated upon along with their analysis in Chapter 2. 
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Protein Bound 3-Nitrotyrosine 
 
 Protein bound 3-nitrotyrosine (P3NY) is a post-translation modification (PTM) found to 
accumulate in several age related diseases. It is a highly studied modification due to its relative stability 
when compared to other oxidative modifications. Because of its relation to the aging process, there is a 
high degree of interest in the role it plays in several disease states from cancer to Alzheimer’s[15].  
 Early investigations into formation of P3NY focused upon peroxynitrite as a source for protein 
oxidation. Extensive work has shown that inflammation of tissue corresponds to an increase in nitric 
oxide release which can react with superoxide to form peroxynitrite. Peroxynitrite itself can degrade to 
form a hydroxyl radical, a potent oxidant, and nitrogen dioxide. These two degradation products support 
the chemical rational for the oxidation of tyrosine to P3NY[16]. Peroxynitrite has been shown to readily 
oxidize tyrosine to P3NY in vitro and is used as a way to easily produce nitrated protein samples needed 
in the development of analytical methods[15]. Continued investigations have shown that there are 
multiple paths for the formation of P3NY, but peroxynitrite and its degradation products are thought to 
remain a prominent source for protein oxidation.  
 There is much debate regarding whether or not P3NY is a PTM of relevance or if it is just a 
consequence of other oxidative mechanisms within disease states[16]. Work done by MacMillan-Crow et. 
al. showed peroxynitrite exposure can result in nitration of Tyr34 in manganese superoxide dismutase 
(MnSOD)[17]. Tyr34 resides in the active site of MnSOD and nitration at this site results in complete 
inactivation of MnSOD. This loss of function shows a primary way in which P3NY can responsible for 
cellular damage and play a role in formation of disease states and has been heavily implicated as a cause 
for ALS. An additional PTM of interest is the nitration of Tyr74 in cytochrome c. Exposure to nitrating 
conditions has been shown to produce site directed nitration of cytochrome c[18]. Although cytochrome c 
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has been shown to exhibit weak activity as a peroxidase, after nitration of Tyr74, peroxidatic activity is 
shown to increase [19]. The consequence of this gain of function is still under investigation. 
 Historically, P3NY has been detected through western blot analysis by use of antibodies against 
P3NY. Such approaches suffer from lack of specificity of the antibodies which lead to lack of 
reproducibility. Additionally, cleanup prior to western blots are laborious and time intensive. Within the 
past decade, approaches for P3NY analysis have focused on reduction of P3NY to protein 3-
aminotyrosine and subsequent derivatization.  Initial approaches focused in the development of new 
derivatization reagents are described in Chapter 3. Continued elaboration of these approaches and 
utilization of newly developed derivatization reagents is described in Chapter 4. 
 
1.3 Preferred Methods Analysis 
 
High performance liquid chromatography (HPLC) is the preferred method of separation found 
within this body of work. A typical conventional HPLC is composed of a liquid pump, an autoinjector, a 
packed chromatography column, and can be connected to a wide range of detectors. Reverse phase 
chromatography is the most common separation format utilized in the following work. A conventional 
reverse phase column is typically a metal tube from five to 25 cm in length with a 4.6 mm inner 
diameter. The column is packed with a stationary solid-phase material composed of 2-10 µm particles 
whose chemical composition is commonly C18 chains bonded to a silica backbone. The analytical sample 
is introduced to the head of the column by the auto-injector, which transfers the sample of interest 
from a vial onto the column. Mobile phase is then pumped through the column. As analytes partition 
from the solid phase to the mobile phase, they move along the length of the column (when in the 
mobile phase) and begin to separate. This separation phenomenon is based on differences in the rate of 
partitioning which is governed by the analytes affinity, or selectivity, towards both the solid phase and 
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the mobile phase. After an analyte has eluted from the column, it can be detected by a variety of 
methods mentioned in subsequent paragraphs.  
The historical precedence for HPLC has shown while it may never be the best method of 
separation for a single set of analytes, being typically inferior in plate counts to gas chromatography and 
capillary electrophoresis, it is a robust mode of separation for small molecules, peptides, and even 
proteins. The robustness of HPLC, along with its compatibility with most forms of detection, has made it 
a favored means of separation. The theoretical background of HPLC and advancement of the technology 
is explored further in the appendix chapter to this thesis.  
HPLC coupled with electrochemical detection (ECD) has been widely used for detection of 
catechols. ECD works with HPLC by placing a pair of electrodes post column in the effluent and applying 
a potential across the electrodes. As molecules pass the electrodes they can be reduced at the cathode 
or oxidized at the anode, which makes this form of detection ideal for proquinoidal compounds. 
However, ECD can exhibit issues with selectivity, require long acquisition times, and require pmols of 
material due to poor sensitivity[20].  
Recently, mass spectrometry has been utilized in the detection of proquinoidal compounds due 
to its high specificity and ever increasing sensitivity[21]. Mass spectrometers typically consist of an 
ionization source followed by a detector capable of separating gas phase ions. There are several 
different sources for both ionization and detectors for separation. The mass spectrometer utilized within 
this work was a quadrupole time of flight (QToF) hybrid mass spectrometer with an electrospray 
ionization (ESI) source.  
Electrospray ionization is a soft ionization technique where the liquid flow from an HPLC is 
aerosolized by a non-reactive nebulizing carrier gas (typically nitrogen). This aerosol spray enters an 
electric field where the droplets deform until reaching its Raleigh limit. At this limit they explode 
producing subsequently smaller droplets[22]. Heat can be applied to assist in the evaporation of solvent 
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from the smaller droplets which results in the analyte taking on charge from the mobile phase forming a 
gas phase ion that is directed via electric fields towards the mass analyzer. 
Quadrupole mass analyzers are composed of four cylindrical metal rods of equal dimensions 
arrayed parallel to each other. The rods act in two sets with a radio frequency voltage being applied to 
each set with a DC voltage applied over the RF voltage. These voltages direct gas phase ions down the 
center of the quadrupole and act as a mass filter.  
A ToF mass analyzer is composed of two regions. In the first region, ions are allowed to collect 
on a microsecond time scale and then an electric potential is applied. The gas phase ions absorb kinetic 
energy which accelerates them into the field free region. The time required for analytes to reach the 
detector plate is determined by their mass as E = mv2 where E is energy, m is mass, and v is velocity. As 
the ions are given the same energy, their mass determines the velocity with which they move through 
the field free region resulting in separation of different masses. 
  As access to highly sensitive mass spectrometers is not always guaranteed, a different means of 
detection of proquinoidal compounds is through derivatization to produce a fluorescent reporter 
molecule. This has been classically accomplished through use of ethylenediamine as a derivatization 
reagent[23]. This approach at detection later expanded to utilize diarylethylenediamines[24]. Such 
derivatizations were expanded as it was realized benzylamine can also produce a fluorescent product 
under oxidative conditions[25]. This derivatization scheme is favored for a variety of reasons. First, the 
necessary reagents are widely available at low cost when compared to other reagents used for 
fluorescence measurements. The derivatization only produces a fluorescent product when a catechol or 
5-hydroxyindole is present, making for a highly selective reaction. Finally, the fluorescence profile 
exhibits excitation/emission spectra of 360/460 nm, which is outside a large portion of auto-
fluorescence that occurs with relevant biological samples [26]. In addition to the highly sensitive and 
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selective nature of these favored fluorescent derivatization reactions, the products allow detection of 
femtomole (fmol) amounts of analyte or less [27].  
 
1.4 Summary and Specific Aims 
 
 The goal of the present work was to enhance the analysis of biologically relevant proquinoidal 
compounds. The first series of these compounds found in Chapter 2 are catechols, catecholamines, and 
5-hydroxyindoles. Work on those compounds aims to further elaborate upon previously established 
derivatization protocols using benzylamine (BA) and 1,2-dihydroxyphenylethylenediame (DPE) as 
derivatization reagents. This is accomplished through derivative product isolation, establishing reaction 
rate profiles, and comparing relative yields for both classes of reagents. With derivatization work from 
Chapter 2 as a foundation, Chapter 3 explores synthetic routes towards modification of BA and DPE. The 
goal of that work is to provide added functionality to aid in analysis of the other proquinoidal target: 
protein 3-nitrotyrosine. Finally, Chapter 4 utilizes the newly synthesized reagents and shows initial work 
featuring comparisons of those reagents. 
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Chapter 2 
The Derivatization of Proquinoidal Analytes with 1,2-Diphenylethane-1,2-Diamine (DPE) and 
Benzylamine (BA): An Investigation of Products, Yields, Kinetics and Reagent Selectivity 
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2.1  Introduction 
In the present investigation, the term proquinoidal analytes refers any of a group of substances 
that possess structural moieties allowing for their facile conversion to reactive quinoidal or 
iminoquinoidal products in the presence of mild oxidizing agents.  Substances such as 2-hydroxyphenols 
[1], 2-aminophenols [2-4] and 5-hydroxyindoles [1] that may possess a variety of substituents (e.g., alkyl, 
amino-alkyl, carboxy-alkyl) at different positions fulfill these requirements.  Figure 2-1 illustrates 
structures and initial oxidation products for model analytes (1a, 1b, 5) and the biologically relevant 
substance, epinephrine (3), which exhibit this property.  
From a broader perspective, substances of biological interest with this feature include the 
catecholamines (CAs), catechols (Cs), 5-hydroxyindoleamines (5-HIs) [1], and post-translational 
modifications (PTMs) of protein tyrosine residues, such as protein-DOPA (P-DOPA) [5] and protein 3-
nitrotyrosine (P-3NY) [6], which becomes proquinoidal upon reduction to the protein-3-aminotyrosine 
(P-3AY) [2].  A non-exhaustive list of examples for the first three groups include; the CAs epinephrine (E), 
norepinephrine (NE) and dopamine (DA); the Cs, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-
dihydroxymandelic acid (DOMA) and 3,4-dihydroxyphenylethyleneglycol (DOPEG); and the 5-HIs, 
serotonin (5-hydroxytryptamine, 5-HT), 5-hydroxytryptophan (5-HTP) and 5-hydroxyindoleacetic acid (5-
HIAA), with P-DOPA and reduced P-3NY (P-3AY) representing the last category.  Each of the substances 
arises from biosynthetic modification of the two amino acids, tyrosine [7] and tryptophan [8]. CAs and 5-
HIs represent substances serving as neurotransmitters that are important in various CNS functions [7-
10], while in contrast the Cs arise from deamination of CAs, and are of interest in various disease states 
[11-13]. P-3NY is a stable post-translational modification (PTM) of protein tyrosine residues, which is 
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formed as a result of exposure to reactive nitrogen species (RNS) and thus serves as a biomarker of 
oxidative stress [6].   
Due to the involvement of CAs, Cs and 5HIs in a myriad of biologically important activities, there 
has been a long-standing and continuing interest in the development of methodologies for their 
sensitive and selective determination in biological tissues and fluids.  Because of their inherent ease of 
oxidation (pro-quinoidal nature), liquid chromatography with electrochemical detection (LCEC) has been 
established for the determination of these analyte classes since the 1980s. In a recent publication, 
Yamaguchi provides an overview that summarizes attributes and limitations of the emergence and 
continued advances in LCEC for their determination [1].  Over the same timeframe, and continuing for 
the next two-decades, the Ohkura and Yamaguchi groups, described the fluorogenic derivatization of 
various CAs and Cs with diphenylethylenediamine (DPE) [1,14] and 5-HIs [1,15], with benzylamine, 
respectively (BA). Each derivatization reaction is initiated by an oxidation step to form a reactive 
quinoidal intermediate (Figure 2-1: 2,4,6) followed by reaction with the fluorogenic reagents in a series 
of steps, in each case culminating in the formation of a fluorescent 2-phenylbenzoxazole (PBO) moiety 
within the overall product structure (Figure 2-2: 7a,7b,8,9) [15,16].     
  During the development of these derivatization reactions, the researchers reported structures 
of the fluorescent products, initially for 5-HIs with BA [15] (Figure 2-2: 9) and subsequently for CAs with 
DPE [16] (Figure 2-2: 8).  With respect to 5-HIs derivatized with BA, the product structure was based on 
prior reports of substances possessing analogous structural features [17,18], while the structure of 
product (8), resulting from derivatization of the epinephrine (3) with DPE, was elucidated via isolation 
and characterization by MS and NMR techniques [16]. Similar products would be expected from the 
derivatization of all 3,4-dihydroxyphenylethylamines (Figure 2-2: 8). In a prior publication it was noted 
that when various CAs and Cs were derivatized with DPE, the fluorescent products all exhibited similar 
excitation (~350 nm) and emission (~480 nm) spectra [14]. However, the specific structure of products 
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resulting from DPE or BA derivatization of Cs was not reported.  Due to our interest in developing 
methodology for the aforementioned PTMs of protein tyrosine, there was a need to elucidate the 
product resulting from derivatization of Cs with BA and/or DPE.  Using 4-methylcatechol (4MC; 1a) as a 
model of P-DOPA and 2-aminocresol (2AC; 1b) as a model for reduced P-3NY (P-3AY), previously we 
have reported that derivatization of 4MC (1a) or 2AC (1b) with BA leads to the formation of the 6-
benzylamino-2-phenylbenzoxazole (BAPBO) [2] (Figure 2-2: 7a).  Subsequently, in unpublished research 
we found that derivatization of 4MC (1a) with DPE resulted in the 6-amino-2-phenylbenzoxazole (APBA) 
(Figure 2-2: 7b).  The details of this reaction will be reported herein.  
The determination of these analyte classes with these regents has been a continually evolving 
process. As previously noted BA was initially used for the derivatization of 5-HIs, but in a following 
publication Yamaguchi et al. report the simultaneous determination of serotonin and norepinephrine via 
pre-column derivatization with BA [19].  This approach follows a previous report where it was 
established that BA (and various substituted analogs) undergoes reaction with CAs to apparently form 
the same products as those obtained from DPE [20].  More recently Yamaguchi and co-workers have 
developed a two-step reagent addition sequence for derivatization of samples containing each analyte 
class [21].  The methodology was based on an initial rapid derivatization of 5-HIs with BA (2 minutes at 
room temperature), followed by derivatization of the CAs and Cs by addition of DPE and the 
"accelerator" glycine (gly) [14] using a higher reaction temperature (20 minutes at 50 °C).  Interestingly, 
it was asserted that 5-HIs have low or no reactivity towards DPE and that CAs and Cs have low or no 
reactivity towards BA, thus enabling the described selective derivatization of these analytes with 
different reagents; however, the selective reactivity claims seem to be in contrast to the BA based 
method previously noted.  Upon close scrutiny, the claims of reagent-analyte reactivity selectivity would 
appear to be questionable.  For example, in the first step the transformation of 5HIs by BA is clearly 
rapid; however, it is not obvious that DPE is unreactive with the quinoid intermediate formed from 5-
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HIs.  Further, upon execution, of the second step by the addition of DPE/gly there will be substantial 
quantities of BA remaining to react with the CAs and Cs.  In the case of CAs, whether DPE or BA mediates 
the formation of the fluorescent benzoxazole is irrelevant, with the same product being formed in either 
case.  With regard to Cs, previously we have observed that reaction with BA leads to formation of 
BAPBO (Figure 2-2: 7a) derivatives [2] and, with data to be presented herein, that APBA (Figure 2-2: 7b) 
products are formed from reaction with DPE.  Thus in the two-step protocol the potential arises for the 
formation of two products from Cs when both BA and DPE are present as reagents. From a chemical 
standpoint one may question the claim that 5-HIs exhibit low or no reactivity towards DPE.  Since 
reaction of DPE with quinoidal intermediates arising from CAs (Figure 2-1: 4) and Cs (Figure 2-1: 2) leads 
to the formation of substituted PBO derivatives (Figure 2-2: 8 and 7b), it would seem plausible that as 
BA reacts with 5-HI derived quinoid substances (Figure 2-1: 6) to form PBO derivatives (Figure 2-2: 9), a 
similar result would be obtained from reaction of the quinoid with DPE (Figure 2-1: 6).  In this regard, we 
have observed that reaction of BA or DPE with 5-HIs and certain other ortho-quinones results in the 
formation products analogous to 9 (Figure 2-2).  
One additional aspect of basic chemical interest is the use of gly as an "accelerator" in the DPE 
derivatization of CAs and Cs.  Past publications describe the preparation of the DPE reagent as a solution 
being composed of gly and DPE, the gly component being present at equivalent or higher concentrations 
with respect to the DPE.  Typical derivatization protocols result in DPE (and gly) being present in molar 
excess of 105-106 as compared to the analytes.  With the reaction being conducted at high pH values, 
typically pH 10, a large fraction of the gly will be present as the nucleophilic species (free amine), and 
with respect to the quinoidal species arising from Cs or 5-HIs (Figure 2-1: 2 and 6) there is the potential 
for the interception of such intermediates by nucleophilic gly, thus creating an alternate non-productive 
reaction pathway leading to an overall diminished yield of the desired fluorescent product.  
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In the preceding paragraphs, many aspects of DPE and BA mediated fluorogenic derivatization of 
proquinoidal analytes of biological interest (5-HIs, CAs, Cs) were presented.  Further it was pointed out 
that reduced P-3NY (P-3AY) substances, due to their proquinoidal nature would exhibit much of the 
same chemistry, thus the model substances 4MC (Figure 2-1: 1a) and 2AC (Figure 2-1: 1b) would be 
expected to possess similar chemical reactivity and undergo similar reaction pathways with either of the 
noted reagents.  However, there are details of these reactions that have not been explored in the past 
or perhaps could be further clarified.  Many of these aspects will be addressed presently using several 
substances where the products of the reactions are probed by mass spectrometry, and in other cases 
using various substances as models (Figure 2-1: 1a, 3,5)  for 5-HIs, CAs and Cs.  As noted previously, 
presently we will report the product of DPE with the model 5-HI 5 (Figure 2-1) and the model catechol 
1a (Figure 2-1) and we have prepared the products 7a, 7b, 8 and 9 (Figure 2-2) thus enabling 
derivatization reaction yield determinations. In the present investigation, the derivatization kinetics of 
these reactions are explored, including the role played by the "accelerator" gly in DPE derivatizations, 
which we expect to be of particular interest in the derivatization of Cs where the internal nucleophile (β-
amino-alkyl substituent of the CAs) is absent in the Cs family of analytes.  Finally, we will report results 
obtained from the derivatization of 4MC conducted with BA, DPE and gly, present in various 
combinations.   
 
2.2 Experimental 
 
2.2.1 Reagents and Solvents 
 
Benzylamine (BA), meso-1,2-diphenylethylenediamine (DPE), 4-methylcatechol (4MC), 5-
benzyloxyindole-2-carboxylic acid ethyl ester, palladium on carbon (Pd/C), N-cyclohexyl-3-
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aminopropanesulfonic acid (CAPS), formic acid (FA), 2-amino-p-cresol (2AC), ammonium bicarbonate, 
and potassium hexacyanoferrate (K3Fe(CN)6) were obtained from Sigma-Aldrich (St. Louis, MO, USA) and 
were used as received. Methanol (MeOH), hexanes (Hx), methylene chloride (CH2Cl2), acetone 
(CH3)2CO), tetrahydrofuran (THF), and ethyl acetate (EtOAc) were all HPLC grade and purchased from 
Fisher Scientific (Pittsburgh, PA, USA). Purified water was obtained from a Labconco Water ProPS 
Filtration Apparatus (Labconco Corporation, Kansas City, MO, USA).  
 
2.2.2 Mass Spectrometry and NMR 
 
The University of Kansas Mass Spectrometry & Analytical Proteomics Laboratory preformed 
high-resolution molecular mass determinations using a Q-Tof-2 mass spectrometer (MicroMass Ltd., 
Manchester UK) equipped with an electrospray ion source.  HPLC-F-MS determinations utilized for 
product screening were conducted with the following system: a Waters Associates Alliance 2690 
chromatograph, Shimadzu RF-535 fluorescence detector and a MicroMass QuattroMirco mass 
spectrometer.  NMR spectra were acquired used a Bruker Avance DPX 400 instrument and  Bruker 500 
MHz instrument equipped with a dual carbon/proton cryoprobe.  
 
2.2.3 HPLC-Fluorescence Detection (HPLC-F) 
 
General Aspects.  All kinetic and yield data was collected on a Shimadzu LC-10 series HPLC 
consisting of an SLC-10A vp system controller, two LC-10AD vp pumps, and SIL-10AD vp  auto-injector 
and a RXL-10A xl fluorescence detector set at 360 nm excitation and 460 nm emission. Separations were 
performed with a Phenomenex HPLC column (4.6 mm x 150 mm; ODS-3 particles, dp 5µm, pore 100 
Å).  Mobile phase A (MP-A) (consisted of 0.1% FA in 90:10 H2O:MeOH and mobile phase B (MP-B) 
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consisted of 0.1% FA in 10:90 H2O:MeOH. Unless otherwise noted, 20 µL injection volumes were 
throughout with a 1.0 mL/min flow rate. 
Chromatographic Details.  Protocol 1: For the 4MC/DPE(1a7b) derivatization, isocratic 
chromatography was conducted using 30:70 MP-A:MP-B. Protocol 2:  All other kinetic and yield 
investigations (1a7a; 38; 5b9b) used an isocratic separation with 100% mobile phase B.  Protocol 
3:  For the investigation of reactions containing a mixture of products, starting conditions used 30:70 
MP-A:MP-B, followed by a linear gradient to 100% MP-B over 5 minutes, a 5 minute hold, then a return 
to the initial conditions with a 5 minute re-equilibration time prior to the next injection. Yield 
Determinations. For yield investigations, peak areas of the peaks of interest resulting were compared 
against single point calibrations of the previously synthesized reference substances for determination of 
required reaction times and resulting yields.  
 
2.2.4 Synthesis of Derivatization Products - General Aspects 
 
The derivatization products (7a, 7b, 8, and 9) that were used in the yield investigations were 
prepared according to the procedures described in the following paragraphs.  In each case the products 
were purified by preparative chromatography, and provided the expected results for 1H NMR and high 
resolution mass spectrometry (HRMS).  Only the E (8) reference substance was not subjected to HRMS 
as it was similar in all respects a previously reported preparation [16].  Each preparation provided a 
single peak, which co-eluted with the in situ generated derivatization product, when examined by HPLC 
with fluorescence detection. 
Synthesis of the 4MC/BA Reaction Product (7a). The 4MC/BA reaction product was synthesized 
according to a previously published procedure [2]. To a 500 mL RBF, a solution of 2.0 g of 4-MC dissolved 
in 125 mL of MeOH was added to 125 mL of purified H2O. Solid K3Fe(CN)6 (5.0 g) was slowly added to the 
19 
 
solution, following by addition of BA (25 mL) over 1 hr.  After stirring for 3 hrs, MC (200 mL) was added 
to the dark brown reaction mixture and stirring continued an additional 0.5 hr.  Subsequently, the 
reaction was filtered, the organic phase recovered and washed 5x with equal volumes of H2O, recovered 
and dried with Mg(SO4)2, and concentrated in vacuo (~10 mL).  Product isolation was accomplished by 
low-pressure preparative chromatography (25mm x 200 mm glass column) on silica gel (200-440 mesh, 
60 Å), utilizing a mobile phase composed of EtOAc:Hx (2:8).  The desired fraction, visualized on-column 
by exposure to the long wavelength of a hand-held UV lamp (Model UVGL-25; UVP, Upland, CA), was 
collected, and the solvent evaporated under reduced pressure to provide a solid, which after 
recrystallization from CH3)2CO/H2O and drying (80 °C for 4 hrs in vacuo) resulted in yellow crystals, m.p. 
143 °C (uncorrected). 1H NMR ((CD3)2CO)) δ 7.1 (2H, m), 7.5(3H, m), 7.4 (5H, m), 7.25 (1H, t, J = 7.3), 6.65 
(1H, s), 4.5 (2H, s), 2.35 (3H, s) (spectra available in supplementary information); MS (ESI) m/z calc. for 
C21H19N2O [M+H]
+: 315.1497, found: 315.1501. 
Synthesis of the 4MC/DPE Reaction Product (7b. To a solution of 7a (0.5 g) in THF (20 mL) 
contained in a 100 mL RBF was added Pd/C (50 mg), the headspace purged with hydrogen, and the flask 
fitted with hydrogen filled balloon. The resulting suspension was magnetically stirred for 24 hours, 
followed by filtration through a Celite pad, the solvent removed in vacuo to provide a solid, which was 
taken up in EtOAc and purified by low-pressure preparative chromatography (25mm x 200 mm glass 
column) on silica gel (200-440 mesh, 60 Å), utilizing a mobile phase composed of EtOAc:Hx (25:75).  The 
product containing fraction was isolated and the solvent removed in vacuo to provide solid 7b, 218 °C 
(uncorrected).  1H NMR (DMSO)  δ 8.1 (2H, m), 7.55 (3H, tdd), 7.35 (1H, s), 6.9 (1H, s), 5.1 (2H, s), 2.2 
(3H, s) (spectra available in supplementary information); MS (ESI) m/z calc. for C14H13N2O [M+H]
+ 
225.1028, found: 225.1008.   
Synthesis of E/BA Product (8). To a stirred solution of epinephrine (1.65 g), prepared by 
dissolution in equal parts of MeOH:H2O (650 mL), was added BA (10 mL) and solid K3Fe(CN)6 (5.92 g), 
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followed by additional BA (10 mL).  The reaction was continued for 4 hrs, after which time the MeOH 
was removed in vacuo and the remaining aqueous reaction mixture extracted 3x with 100 mL aliquots of 
CH2Cl2.  The combined extracts were dried with anhydrous Mg(SO4)2, the filtered to provide a dark 
solution, which was initially fractionated by low-pressure preparative chromatography (25mm x 600 mm 
glass column) on silica gel (200-440 mesh, 60 Å), utilizing a mobile phase composed of ACN.  The long 
wavelength fluorescent band, visualized on-column by exposure to the long wavelength of a hand-held 
UV lamp (Model UVGL-25; UVP, Upland, CA), was collected, and the solvent evaporated to yield a dark 
liquid, which was re-fractionated using a mobile phase of CH2Cl2:ACN (3:1).  The fluorescent band was 
collected and the solvent evaporated in vacuo to provide a brownish solid product 8 that requiring 
further purification by preparative HPLC.  Preparative HPLC was conducted using a Phenomenex Luna 
10µ-PREP C18(2) column (250 x 21.2 mm) using the following chromatographic conditions and 
parameters: MP-A 0.1% FA in H2O, MP-B 0.1% FA in MeOH; flow rate  4.0 mL/min. Approximately 20 mg 
of solid was dissolved in 5 mL of MeOH and 50 µL injected per chromatographic run with was conducted 
according to the following program: time zero, 100% MP-A followed by a linear ramp to 100% MP-B over 
10 min and hold for 4 min, then return to the 100% MP-A and hold for 5 min.  The desired peak was 
collected form each run (30 total), combined, the solvent evaporated to leave 8. 1H NMR (CDCl3) δ 8.2 
(2H, m), 7.6 (1H, s), 7.5 (3H, m), 6.6 (1H, s), 5.3 (1H, dd), 4.5 (1H, dd,), 3.5 (2H, m), 2.8 (3H, s), which is in 
agreement with the previously reported spectra [16]. 
Synthesis of 5-hydroxyindole-2-carboxylic acid ethyl ester (5HI-2-CAE) (9b). To a THF solution (50 
mL) of 5-benzyloxyindole-2-carboxylic acid ethyl ester (5.0 g) contained in a 250 mL RBF was added Pd/C 
(0.5 g). The flask was purged with hydrogen and fitted with hydrogen filled balloon. The suspension was 
magnetically stirred for 24 hrs, filtered through a thin pad of Celite. Addition of H2O (200 mL) resulted in 
formation tan colored needles, which were dried in vacuo at 80 °C to provide the intermediate 5-
hydroxyindole-2-carboxylic acid ethyl ester, which was used without further purification.  [Analytical 
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data: 1H NMR δ 11.6 (1H, s), 9.05 (1H, s), 7.25 (1H, d, 8.8 Hz), 6.95 (2H, m), 6.8 (1H, dd, J = 8.5 Hz, J = 
2.35 Hz), 4.1 (2H, q, J = 7.15 Hz), 1.35 (3H, t, J = 7.1 Hz); MS (ESI) m/z calc. for C11H10NO3 [M+H]
+: 
204.0661, found: 204.0645].  To a solution of this intermediate (0.75 g), prepared in THF (75 mL) and 
MeOH (50 mL), contained in a 500 mL RBF, was added an aqueous solution (150 mL) of K3Fe(CN)6 (8.0 g), 
followed by addition of a BA solution (5 mL dissolved in 75 mL of THF) over 1.5 hrs, with stirring 
continuing for 1 hr.  Subsequently the reaction solution was extracted with EtOAc (200 mL), the organic 
layer recovered and washed an additional 2x with an equal volume of H2O, followed by in vacuo 
concentration to approximately 10 mL, which was subjected to low-pressure preparative 
chromatography (30 mm x 600 mm glass column) on silica gel (200-440 mesh, 60 Å), utilizing a mobile 
phase composed of EtOAc:Hx (10:90). The desired fraction was collected and evaporated to provide 9b 
as a solid product. 1H NMR (DMSO) δ 9.2 (1H, s), 8.35 (2H, m), 7.75 (1H, dd, J = 2.15 Hz, J = 0.95 Hz), 7.65 
(1H, d, J =  8.85 Hz), 7.55 (3H, m), 7.45 (1H, dd, J = 9.0 Hz, J = 1.0 Hz),  4.45 (2H, q, J = 4.60 Hz), 1.5 (3H, t, 
7.15 Hz) (spectra available in supplementary information; MS (ESI) m/z calc. for C18H15N2O3 [M+H]
+: 
307.1083, found: 307.1072. 
 
2.2.5 Derivatization for Kinetic and Yield Determinations 
 
A diluent buffer solution consisting of 50% CAPS (0.3 M, pH 10.0) and 50% MeOH, was used for 
all dilutions, being discarded after one week.  For ammonia incubation studies, a NH4HCO3  (0.1 M, pH 
8.1) buffer was substituted for the CAPS buffer in the diluent solution. Stock solutions (1.0 mM) of the 
synthesized products (7a, 7b, 8 and 9b)  were prepared in MeOH and stored at 4 °C, then diluted 100 
nM with MeOH immediately prior to injection. Analyte stock solutions (1.0 mM) of 1a, 3 and 5b were 
prepared in methanol, stored at 4 °C, and diluted to 1 µM with MeOH:H2O (1:1) to prior to 
derivatization. Stock solutions of the derivatization reagents BA (0.3M) and DPE (0.3M) were prepared 
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daily in the diluent buffer solution. Stock solutions of K3Fe(CN)6 (10 mM ) and gly (0.3M) were prepared 
in the diluent buffer solution and used within 24 hours.  Derivatizations were conducted by adding the 
following solutions to a 1.7 mL auto-sampler vial in the following order:  700 µL diluent buffer; 100 µL 
analyte; 100 µL K3Fe(CN)6, and 100 µL of derivatization reagent.  This resulted in reaction concentrations 
of 100 nM analyte, 1mM K3Fe(CN)6, and 30 mM derivatization reagent.  For derivatizations containing 
glycine, the following solutions were added to a 1.7 mL auto-sampler vial in the following order: 600 µL 
of diluent buffer, 100 µL of analyte, 100 µL of K3Fe(CN)6, and 200 µL of gly:DPE (1:1). This provided for 
reaction concentrations of 100 nM analyte, 1 mM K3Fe(CN)6, 30 mM glycine and 30 mM DPE.  The same 
procedure was used for investigation of the ammonia loading experiments with the exception being that 
NH4HCO3 buffer was substituted for the CAPS buffer and the analyte solution containing K3Fe(CN)6 was 
incubated at room temperature for 0, 1, 2, and 4 hours prior to addition of BA.  In all experiments, after 
the completion of all reaction components (and during incubation periods) the vials were sealed, vortex 
mixed for 5 seconds, and then loaded into the autosampler at room temperature. Injections (20 µL) 
were made every 10 minutes. 
 
2.2.6  Derivatization of 4MC Exploring Reagent Selectivity and Gly Effect 
 
The results of these experiments are shown in Figure 2-16A-B, with the details of each 
derivatization as follows.  Figure 2-16A, the derivatization of 4MC (1a) with BA (~100-200 nM final 
concentration) was conducted as described in the previous section.   Figure 2-16B, the derivatization of 
4MC (1a) with DPE was conducted according to the standard protocol, except 100 µL of 7a, (4MC-BA 
product), was substituted for 100 µL of the diluent buffer solution.  Figure 2-16C, 4MC (1a) was 
derivatized with BA and DPE, with 100ul of the diluent buffer being substituted by 100 µL of the 
additional reagent solution.  Figure 2-16D, 4MC (1a) was derivatized with BA per the standard protocol, 
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with the diluent buffer being 600 µL, and as described in the previous section 200 µL of  gly:DPE solution 
utilized in order to examine the effect of each reagent in the presence of gly.  In all cases the total 
reaction volume was 1.7 mL and the reaction conducted for 1.5 hours at ambient temperature prior to 
determination by HPLC-F protocol 3 (described in a previous section) using 40 µL injections. 
 
2.3 Results and Discussion 
 
2.3.1 Products from Derivatization of 5-HIs with BA and DPE 
 
BA has been reported as a fluorogenic reagent for 5-HIs in the early 1990s [15], with the 
structure of the product based on the previously known transformation (oxidative conditions followed 
by reaction with BA) of 1,4-dimethyl-6-hydroxycarbozole [17,18], a substance possessing the 5-
hydroxyindole moiety within the overall structure.  The reaction sequence is based on the 
transformation of analyte 5 (Figure 2-1) through the quinoid intermediate 6 (Figure 2-3) to the PBO 9 
(Figure 2-3).  Presently, this reaction has been investigated using 5-hydroxyindole and 5-hydroxyindole-
2-carboxlic ethyl ester (5-HI-2-CAE) as model analytes. For 5-hydroxyindole, the derivatization reaction 
was conducted using BA or DPE, with the products subjected to LC-FL-MS analysis.  For each reagent, the 
fluorescent products (Figure 2-2: 9a and 9b) co-eluted chromatographically, exhibited the same 
fluorescence properties (excitation and emission maximum of 375 nm and 475 nm) and the same mass 
spectrum, [M+H]+ m/z = 235 [22].  Product 9a was found to be unstable when attempts to isolate 
preparative quantities were undertaken (likely due to oxidation with positions 2 and 3 being 
unsubstituted) [22].  To avoid this liability, the reference standard sought was prepared from reaction of 
5-hydroxyindole-2-carboxylic acid ethyl ester (Figure 2-1: 5b) with BA resulting in product 9b (Figure 2-
2).  LC-MS characterization of the 9b provided the expected mass spectrum; [M+H]+ m/z = 307 [22].  As 
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in the previous case, when analytical scale derivatizations of 5b (Figure 2-1) were conducted with either 
BA or DPE identical products were produced.  These overall chemical pathways are summarized in 
Figure 2-2, with the proposed detailed reaction pathway for PBO formation shown in Figure 2-5. Aspects 
regarding the mechanism, kinetics and yield of these reactions, for each reagent, will be presented in a 
following section. 
 
2.3.2 Products from Derivatization of CAs with BA and DPE 
 
The fluorescent product resulting from the derivatization of the catecholamine epinephrine 
(Figure 2-2, 8) was isolated and characterized by NMR and MS a number of years ago [16].  Prior 
publications have described the use of both reagents, DPE [23] and BA [19], for the derivatization of 
various catecholamines, with apparently the same fluorescent product being obtained from the use of 
either reagent and in all cases the fluorescent spectra and chromatographic properties support this 
conclusion.  Presently the derivatization of 8 (Figure 2-2) was conducted on the analytical scale using BA 
and DPE, and product formed from each reagent co-eluted chromatographically, displayed identical 
fluorescence properties (excitation and emission maximum of 360 nm and 460 nm, respectively), and 
exhibited identical mass spectra, [M+H]+ m/z = 267 (data not shown).  In order to obtain a reference 
standard, the derivatization was conducted on the preparative scale using a slight modification of the 
previously published procedure (details are provided in the experimental section), with the major 
difference being the use of BA instead of DPE.  The product (Figure 2-2, 8) was isolated, purified and 
found to exhibit identical chromatographic properties as the derivative formed from either reagent on 
the analytical scale.  A proposed product formation mechanism is shown in Figure 2-9.  Kinetic, yield and 
mechanistic aspects for this product and CAs in general will be discussed in a following section.   
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2.3.3 Products from Derivatization of Cs with BA and DPE 
 
In a previous publication from these laboratories [2], the product arising from BA derivatization 
of Cs such as 4MC (Figure 2-1: 1a) and the o-aminophenol 2AC (Figure 2-1: 1b) was reported and is 
depicted by structure 7a (Figure 2-2).  At the onset of this prior research, it was not immediately obvious 
that this derivatization reaction would result a 6-amino substituted PBO (Figure 2-2: 7a); however, in 
prior reports [14] and confirmed in our past investigation, it was noted the product formed exhibited 
fluorescent characteristics similar to those observed with the CA derivatives.  While similar fluorescent 
properties were noted for the derivatization of 4MC with DPE, a detailed examination of the product 
formed via use of DPE was not reported.  In order to probe the structures of the products formed, 3,4-
dihydroxycinnamic acid (DHCA) and 4MC were derivatized with BA and DPE and the reaction solutions 
examined by LCMS [22].  The product formed from BA derivatization of DHCA exhibited a mass spectrum 
of [M+H]+ m/z = 371 and for 4MC derivatized with BA [M+H]+ m/z = 315 (previously reported)[2], which 
is consistent with the 7a type general structure presented in Figure 2-2 with R1: CH=CHCO2H and CH3, 
respectively.  In the case of DPE, DHCA exhibited a mass spectrum of [M+H]+ m/z = 281 and for 4MC 
[M+H]+ m/z = 225.  In each case, the DPE derived product was found to have a -90 Da MW shift as 
compared to the BA product.  As noted in our earlier investigation, the presence of a 6-amino 
substituent on the PBO structure is necessary to provide for the observed fluorescence characteristics, 
thus suggestive of a product bearing a 6-amino substituent for the DPE based products as compared to 
the 6-benzylamino substituent, which has been previously established for the BA based products, with 
this structural difference being illustrated by 7b versus 7a in Figure 2-2.  While this conclusion is clearly 
supported by the fluorescence and MS data [22], further proof was sought by the independent synthesis 
of the 7b type derivative for 4MC.  In general, we have found that the preparative scale synthesis of 
various PBO derivatives from reaction of the requisite catechol with DPE prove problematic due the 
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formation of a multiple unknown substances along with the desired product.  As a result 7b was 
prepared from the known 7a via catalytic reduction to remove the N-benzyl substituent (details for the 
preparation of each compound are described in the experimental section).  This product was found to 
provide identical chromatographic, fluorescence and mass spectral properties to the analytical scale 
derivatization product previously noted and was used as a reference standard in the characterization of 
the yield and kinetic studies of this reaction.  Clearly DPE is serving as an amine donating agent in the 
derivatization of Cs.  The mechanistic aspects of this role will be discussed in a following section. 
 
2.3.4 Rate, Yield, and Mechanism for 5-HICAE derivatization with BA and DPE 
 
The next aspect of this investigation was the characterization of the derivatization kinetics and 
yield of the model 5-HICAE (Figure 2-1: 5b).  The model selected was based on considerations of 
perceived product stability and accessibility of the synthetic route.  As compared to serotonin and other 
5-HIs, 5-HICAE possesses a 2-carboxyethyl substituent rather than a 3-alkyl substituent on the indole 
ring system, which was perceived to not substantially bias the derivatization kinetics as substances 
substituted in either position should readily undergo oxidation to the reactive quinoid intermediate.  
The reaction was conducted at ambient temperature in an autosampler vial and periodically analyzed by 
HPLC-F until completion of the reaction as evidenced by an unchanging maximal product peak area.  The 
concentrations of reactants were as follows: 5-HICAE, 100 nM; K3Fe(CN)6, 0.1 µM; BA or DPE, 30 mM, 
which resulted in a relative ratio of 1:10:300,000 analyte to oxidant to reagent, respectively.  
Chromatograms illustrating the time course for derivatization of 5-HICAE with BA are shown in Figure 2-
3. Time course plots of data obtained from 5-HICAE derivatization with three differing reagent systems 
(BA, DPE or DPE plus gly) are shown in Figure 2-4, with a summary of these data presented in Table 1. 
Interestingly, product yield was observed to be ~ 35% irrespective of which reagent was used or if gly 
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was present with DPE.  However, the reaction was complete within 20 minutes with BA, as compared to 
50 minutes with DPE.  As noted earlier, DPE does form the same product as BA in the derivatization of 5-
HIs and the present results contradict the earlier claim that DPE exhibits low or no reactivity towards 
this class of analytes, albeit a slower reaction was observed. 
As regards the mechanism whereby the same product is formed from either reagent, a plausible 
reaction scheme is shown in Figure 2-5.  As in all of the analyte classes investigated, the reagent 
undergoes a nucleophilic addition to the quinoidal intermediate, followed by tautomerization reforming 
the aromatic system, followed by oxidation to form the o-iminoquinone (6101112).  Continuing 
towards PBO formation, the imine subsequently shifts to the Schiff base (1213), which undergoes 
cyclization (1314) and subsequent formation of the fluorescent product (149b), a step that is likely 
completed via a radical mediated process, where H2 is eliminated when BA is used as the regent, or BA is 
eliminated (fission of the DPE molecule) in the case of DPE as reagent.  The key sequence of reactions 
from 129b previously has been reported for the elaboration of an o-quinone to the PBO with BA [24], 
thus leading strong credence to the presently proposed reaction sequence.  With regard to DPE, the 
only difference would lie in the final step where the DPE molecule undergoes a symmetrical fission 
(149b); however, this would involve the generation of a benzyl radical, a highly plausible step. 
 
2.3.5 Rate, Yield, and Mechanism for CA derivatization with BA and DPE 
 
Continuing this line of investigation, similar experiments were performed for the derivatization 
of the CA epinephrine (E) (Figure 2-1: 3).  The reaction conditions and relative concentrations of all 
reactants were as noted in the previous section.  Chromatograms showing the progress of this reaction 
are shown in Figure 2-6 and, as in the previous case time course plots of data obtained for E 
derivatization with the three different reagent solutions (BA, DPE or DPE plus gly) are presented in 
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Figure 2-7, with an overall summary of the time to completion and yield data summarized in Table 1.  
Examination of these data reveal that irrespective of the reagent system utilized, including the presence 
of gly that was previously claimed to function as an "accelerator", there was no substantial difference in 
time required to complete the derivatization nor difference in product yield.  
A plausible reaction sequence for the various steps involved in the transformation of CAs to the 
PBO products of general structure 8 is presented in Figure 2-8.  In this case the initially formed o-
quinone undergoes an intramolecular Michael addition with subsequent tautomerization followed by a 
further oxidation to form adrenochrome, which then reacts with the reagent forming an o-
iminoquinone (415161718).  As in the case of the previously discussed 5-HIs, this type of 
intermediate (18) proceeds along the same reaction pathway to ultimately produce the observed 
fluorescent PBO product (8).  In the present case, the time for completion of the derivatization reaction 
and yield was invariant with respect to the reagent system utilized, which is in contrast to the previous 
situation where derivatization with DPE required more than twice the reaction time as compared to BA.  
Apparently once the reaction sequence reaches intermediate 15 (Figure 2-8), despite significant 
differences in overall steric bulk, either reagent is equally facile in proceeding to formation of the PBO 
product (Figure 2-8: 8).  Of note, the intramolecular Michael addition (416) serves as a product 
defining step in the overall sequence, as will be seen in the next section, this feature is also found in the 
derivatization of Cs with either reagent and once the sequence reaches intermediate 17, either reagent 
serves to complete formation of the fluorescent PBO product via the illustrated steps 
(171819208).  As noted above, the conversation of a p-amino-substituted o-quinone to a PBO 
derivative has been described via the proposed reaction sequence [24]. 
 
2.3.6 Rate, Yield, and Mechanism for Cs derivatization with BA and DPE 
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The Cs are the remaining class of targeted analytes to be invested, with 4-MC being selected as 
the model catechol.  When 4MC was derivatized with BA or DPE as individual reactions PBO products 
were observed; however, the PBO formed from reaction of BA possesses a 6-(N-benzyl)-amino 
substituent (Figure 2-12: 7a), while derivatization with DPE results in a PBO bearing a 6-amino 
substituent (Figure 2-12: 7b). These experiments were conducted in the same manner as described 
earlier utilizing the three reagent systems (BA, DPE or DPE plus gly).  Chromatograms presented in 
Figure 2-9 and Figure 2-10, display the time course for the PBO product formed from derivatization with 
the BA regent and the DPE reagent (absent gly), respectively, with the data being summarized by the 
plots shown in Figure 2-11.  An overall summary of the results is presented in Table 1, where unlike the 
CA case, the different reagent systems now result in significant differences in time to completion and 
yields of the PBO product.  Derivatization of with BA resulted in completion of the reaction in ~30 
minutes yielding ~ 88%, while in the case of DPE (gly absent) a longer reaction time was required, ~75 
minutes and a slightly diminished yield of ~74% was observed.  In the experiment where the 
"accelerator" gly was present with DPE, the reaction was indeed completed in a shorter time, 20 
minutes in the presence of gly versus 75 minutes in the absence of gly, albeit with a substantially 
diminished yield, 74% in the absence of gly versus 38% in the presence of gly.   
A plausible explanation of these results can be found in the reaction sequence shown in Figure 
2-12, with the 2627 transformation being elaborated in Figure 2-13.  The catechol 4MC undergoes an 
initial reaction forming the electrophilic o-quinone 2a. In contrast to CAs where a facile intramolecular 
reaction is operative (Figure 2-8), in the present case nucleophilic BA or DPE intercepts 2a, forming the 
pathway directing intermediates 21 or 25, for BA or DPE, respectively.  For BA, the reaction sequence 
212223247a follows, which is similar to the pathway previously described for the 
catecholamines (Figure 2-8), ultimately resulting in the formation of the PBO product 7a.  However, in 
the case of DPE intermediate 25 apparently serves as the amine donor in a transamination reaction 
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resulting in formation of intermediate 27, which then proceeds through the PBO forming reaction 
sequence resulting in 7b formation. It appears that conversion of intermediate 26 to 27 requires 
multiple steps. A transamination involving BA undergoing reaction with an o-quinone substrate 
previously has been reported [24].  In the present case, DPE or DPE/gly exclusively resulted in the 
transamination reaction leading to 27 formation, which was not observed with the use of BA as 
illustrated in the reaction sequence 22  23247a (Figure 2-12).  A possible explanation for the 
divergence the DPE and BA reaction pathways is shown in the scheme of Figure 2-13 where oxidation 
results in the conversion of 2630, followed by a tautomerization to form 31, which can undergo 
further oxidation and tautomerization to result in the key species 32.  The transformation of 3132 is of 
particular note when one considers BA versus DPE.  For BA, to affect the observed transamination, the 
imine 31 would require nucleophilic attack (excess BA, -OH or H2O) to form a tetrahedral intermediate 
whose fragmentation completes the amine-transfer to the analyte.  This is not observed.  Alternatively 
for DPE, the transformation of 3132 is highly plausible, being driven by the extended conjugation 
between the DPE phenyl-rings and continuing throughout the analyte skeleton.  Once formed 32 is 
subject to nucleophile attach by any of the species previously noted as well as gly if included in the 
reagent solution. With 27 being a good leaving group, intermediate 33 undergoes a facile breakdown to 
effect transamination, a result that is exclusively observed. 
As to the role of the "accelerator" gly, past derivatization protocols have frequently 
incorporated gly in a 1.5-fold molar excess as compared to DPE [14,21].  In basic media, the gly primary 
amine would be a competing nucleophile and undergo reaction with the o-quinone 2a29.  If gly does 
serve in this role, this would result in an analyte consuming non-productive pathway (NPP) leading to a 
diminished yield, which is observed in the present experiments (Table 1).  As to the acceleration of the 
reaction rate, any species capable of reacting with the analyte or intermediates along the product 
formation pathway in a non-productive fashion, would give the appearance of an enhanced product 
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formation rate, but would be expected to result in a diminished yield. Referring to the kinetic scheme of 
Figure 2-14 and the associated kinetic equations (eq. 1 and eq. 2), one can readily see the result of such 
a competition, both from the perspective of rate and yield of the desired product.  The rate of formation 
of 7b is quantitatively described by eq.1, with the applicable rate constant kobs being related to the sum 
of the path rate constants, thus giving the appearance of an "accelerator" effect when gly undergoes a 
non-productive competing reaction.  Quantitatively the expected yield is shown by eq. 2, where it is 
seen that the productive pathway (k1) is a fraction of all processes competing for the analyte, thus 
predicting a diminished yield when such a kinetic situation is operative, as appears to be true in the 
present case (Table 1).  Based on this kinetic analysis and the present data, there would appear to be no 
basis for the long-standing use of gly as an accelerator in DPE derivatizations of Cs and in fact its 
inclusion in the reagent solution is detrimental with respect to product yield. 
 
2.3.7 Formation of the DPE Product using BA via Ammonia Loading 
 
As noted in the previous section, the derivatization of Cs with BA or DPE results in the formation 
of differing products, with the former reagent resulting in a substantially more hydrophobic product as 
compared to the latter, 7a versus 7b (Figure 2-12).  From a chromatographic standpoint, the conversion 
of analytes to highly hydrophobic products can result in excessive elution times in an isocratic format 
and when utilizing reversed-phase gradient elution one may encounter numerous poorly resolved peaks 
late in the elution profile.  With regard to the physical-chemical properties of the reagents, DPE 
possesses poor aqueous solubility as compared to BA, resulting in the need to conduct derivatization 
reactions in media containing a high percentage of a co-solvent such as methanol.  While acceptable in 
many cases, the broader application to the P-3NY problem via derivatization of the 3AY-type products 
obtained by reduction [3,4] is problematic due to the poor solubility of peptides in such solvent systems. 
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This issue created an interest in exploring the feasibility of producing a DPE-type derivative (Figure 2-12: 
7b) via the use of BA by using a modified reaction protocol.  Recognizing the reactive nature of the 
intermediate o-quinone type substances (2a) and the present results with gly, which indicate that 
reactive amines can undergo Michael addition, a series of experiments were planned to evaluate the 
potential for the dynamic installation of an amino-group at what will become the 6-position.  This was 
undertaken by exposing 4MC to a reaction solution containing K3Fe(CN)6 and an ammonia source 
(ammonium hydroxide or ammonium bicarbonate) for timed intervals prior to addition of BA. The initial 
feasibility was evaluated by LC-F-MS characterization of the reaction products formed and revealed two 
fluorescent products, with the early eluting peak exhibiting [M+H]+ m/z = 225 and the latter eluting peak 
exhibiting [M+H]+ m/z = 315, which corresponds to the DPE product (7b) and the BA product (7a), 
respectively [22].  Utilizing the 7a and 7b product standards additional experimentation was undertaken 
where pH 8.1 ammonium bicarbonate was incubated with 4MC for various times prior to the addition of 
BA. These data (Figure 2-15) reveal that simultaneous exposure to the ammonia source and BA result in 
the predominate formation of the BA product (66%) as compared to the DPE product (28%), while in 
contrast after one hour of exposure to the ammonia source prior to the addition of BA resulted in 
predominate formation of the DPE product (75%) and as compared to the BA product (3%).  Continued 
exposure to ammonia prior to BA resulted in virtually no BA product being formed with the DPE product 
clearly dominating; however, the maximum yield of the DPE product occurred with the one hour pre-
exposure, with increasing times providing a continuing decreasing yield trend, which is obviously due to 
the competition of unknown side-reactions in the formation of the ammonia addition product, 4-amino-
5-methylcatechol, and its fate prior to formation of the comparatively stable PBO products, 7a and 7b. A 
further interest in the use of the ammonium-based buffer lies in its compatibility with LC-MS methods, 
which is of interest in our continuing investigations in the proteomics area; however, the present data 
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suggest that this problem may best be addressed via the synthesis of an appropriate water soluble DPE 
analog. 
 
2.3.8 Reagent Selectivity and Further Aspects of the gly Effect 
 
As described earlier, protocols for the derivatization of mixtures containing 5HIs, CAs and Cs, 
have advocated the use of a two-step procedure where the 5HIs were first derivatized with BA (ambient 
temperature, 2 min), and subsequently the remaining targets subjected to derivatization with DPE/gly 
(50 °C, 20 min) [21].  The basis of the approach was a claimed low or no reactivity of DPE towards 5HIs 
and vice versa for BA towards CAs and CS.  Based on the present results summarized in Table 1 this 
clearly is not the case as either reagent converts 5HI type analytes to the desired fluorescent product, 
albeit taking twice the reaction time for DPE, which indicates each reagent is participating in the 
observed conversion.  With regard to CAs, the present data indicate that the desired transformation is 
effected by either reagent in equal times with similar yields.  As regards Cs, derivatization with DPE/gly 
appears to be an inferior approach, as substantially decreased yields results (Table 1), while use of DPE 
alone results in a similar yield as that attained by BA, but at more than double the reaction time, which 
is the reverse of the previously claimed kinetic selectivity and in this case [21], two differing fluorescent 
products would be formed.  To achieve similar kinetic selectivity one would simply conduct the reaction 
at an elevated temperature in the presence of BA and DPE, which would be expected to lessen the 
presently observed selectivity, thus moving towards equalization for the reaction of each reagent with 
the Cs type analyte. 
To further confirm the above conclusions, a selective group of experiments was conducted for 
4MC (1a) derivatization with each reagent separately (BA or DPE), combined (BA and DPE) and 
combined in the presence of gly (BA and DPE and gly), with the results being displayed in Figures 2-16 
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through 2-19. Figure 2-16 illustrates the derivatization of 4MC (1a) with BA, to provide a single major 
peak eluting at 14.5 min and exhibits co-elution with the isolated standard (7a).  In Figure 2-17 
illustrates the result obtained from derivatization of 4MC (1a) with DPE in a solution spiked with ~100 
nM 7a.  The DPE product 7b eluted at 5.7 min, standard 7b eluting as before being unaffected by the 
derivatization process.  These two experiments clearly show that each reagent reacts with 4MC (1a) to 
form the expected differing products; however the next experiment was used to probe reagent 
selectivity as each reagent was initially present. Examination of Figure 2-18 reveals that 4MC is 
exclusively transformed to the BA-type product (7a), a result that is not unexpected based on the prior 
results summarized in Table 1.  In a last and perhaps most critical comparison, 4MC (1a) was derivatized 
with both reagents (BA and DPE) in the presence of gly, a situation that is widely used in past protocols 
[21,25] (Figure 2-19).  The resulting chromatogram reveals, the transformation of 4MC (1a) to the 
expected BA (7a) and DPE (7b) products in approximately equivalent amounts and the appearance of 
multiple unknown fluorescent products, with the peak eluting at 8.8 min being formed in a significant 
amount.  It is not clear why the DPE related product 7b forms in the presence of gly, whereas it was not 
observed in the previous experiment (Figure 2-18); however, there is the possibility of conversion of the 
gly adduct 29 (Figure 2-13) to 7b through a series of reactions (PBO formation and gly substituent 
decarboxylation and dealkylation) but further investigation is required to support such speculation and 
is beyond our present objectives. Careful scrutiny of early publications reveals the use of gly as an 
accelerator was advocated in the fluorometric derivatization of CAs [14]; however, a following 
publication noted use of the DPE/gly for dopamine derivatization resulted in two peaks when used in 
the pre-column format [26].  The present results together with the note prior results clearly indicate 
that gly serves no analytically useful purpose and in fact is a substantial detriment when used with these 
fluorogenic derivatization reagents. 
 
35 
 
2.4 Summary and Conclusions 
 
In the present investigation we have confirmed the products formed from derivatization of 5HIs 
and CAs; however we have additionally shown that both DPE and BA undergo reaction with each analyte 
to form the same products in each case.  Further we have presently shown that derivatization of Cs with 
BA and DPE lead to different fluorescent products exhibiting similar fluorescence characteristics and are 
of the same general class (PBO).  The preparation of reference standards allowed the determination of 
product yields for these determinations, and significantly revealed that inclusion of gly in the reagent 
solution results in a substantially reduced yield for Cs derivatization.  The kinetic data generated 
essentially dispel earlier claims regarding selectivity, such as the non-reactivity or low-reactivity of DPE 
with 5HIs and vice versa in the case of CAs and Cs where DPE was previously noted to be reactive and BA 
to be of low-reactivity or non-reactive.  Based on an appreciation of the reaction mechanism for the 
derivatization of CS, in particular 4MC in this study, we explored the possibility of installing a less 
hydrophobic 6-amino group instead of a 6-benzyl group via pre-incubation prior the addition of BA to 
complete fluorescent product formation, and while successful, a diminished yield was observed thus 
damping enthusiasm for this approach to achieve formation of a less hydrophobic derivative.  A series of 
comparative derivatizations were performed where it was shown that the expected products were 
attained through the use of BA or DPE alone, or the BA product obtained when used in the presence of 
DPE in the derivatization of 4MC, which meets expectations according to the kinetic results obtained.  
Finally the use of gly to serve as an accelerator or exhibit any role in achieving selectivity is clearly not 
viable and is in fact detrimental and is not recommended to be used in conjunction with these reagents.  
The results obtained from DPE derivatization of Cs suggest that it could be advantageous to prepare a 
DPE-type reagent that bears a hydrophilic substituent providing for greater aqueous solubility, thus the 
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use of this reaction in the determination of peptides bearing the 3-NY modification, the need for which 
we noted in the introduction. 
2.5 Chapter 2 Figures 
 
 
 
 
Figure 2-1. Structures of proquinoid substances of relevance to the present investigation 
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Figure 2-2. Products obtained from the reaction of DPE and BA with the proquinoid structures illustrated in Figure 2-1. 
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Figure 2-3. HPLC-F chromatograms illustrating the time course of product formation from derivatization of 5-HI-2-CAE 
(5b) with BA 
  
39 
 
 
Figure 2-4. Time course of product formation from derivatization of 5-HICAE (5b) with BA, DPE and DPE in the 
presence of gly. 
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Figure 2-5. Proposed reaction sequence for product formation for derivatization of 5-HIs with BA or DPE 
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Figure 2-6. Cascade chromatograms showing product formation from the reaction between E (3) and BA. 
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Figure 2-7. Reaction progress for the derivatization of E (3) with different reagents and combinations. 
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Figure 2-8. Proposed reaction sequence for product formation for derivatization of CAs with BA or DPE. 
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Figure 2-9. Cascade chromatograms showing product formation from the reaction between 4-MC and BA. 
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Figure 2-10. Cascade chromatograms showing product formation from the reaction between 4-MC and DPE. 
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Figure 2-11. Reaction progress for the derivatization of 4MC (1a) with different reagents and combinations. 
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Figure 2-12. Proposed reaction sequence for product formation for derivatization of Cs with BA or DPE. 
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Figure 2-13. Proposed reaction sequence illustrating the non-productive role of gly and DPE transamination in the 
derivatization of Cs. 
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Figure 2-14. Kinetic scheme illustrating the apparent "accelerator" and non-productive role of gly in the derivatization of 
Cs with DPE. 
gly
Non-productive
pathway
7b1a
k2
k1
DPE
where
eq . 1: 7b t = 1a o 1 - e
-k obs t
k obs = k 1 + k 2
eq . 2: 7b  = 1a o
k 1
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Figure 2-15. Derivatization yields of the reaction between 4MC and ammonium bicarbonate for various incubation times 
followed by addition of BA. 
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Figure 2-16. Derivatization of 4MC with BA in the presence of K3Fe(CN)6 to form 7a. 
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Figure 2-17. Derivatization of 4MC with DPE in the presence of K3Fe(CN)6, with standard 7a included for reference. 
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Figure 2-18. Derivatization of 4MC with BA and DPE in the presence of K3Fe(CN)6, with standard 7a present. 
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Figure 2-19 Derivatization of 4MC with DPE and BA in the presence of K3Fe(CN)6, and gly. 
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Analyte Reagent Gly Present %Yield %RSD* Completion (min) 
      
5HI-2-CAE BA no 33.2 0.9 20 
5HI-2-CAE DPE no 34.2 0.7 50 
5HI-2-CAE DPE yes 36.5 0.5 50 
      
E BA no 45.1 1.2 30 
E DPE no 48.3 0.8 30 
E DPE yes 49.0 0.3 30 
      
4MC BA no 88.2 1.7 30 
4MC DPE no 73.9 4.5 75 
4MC DPE yes 37.5 3.3 20 
      
N = 3 
Table 2-1. Summary of kinetic and yield experiments for model 5-HIs, CAs and Cs derivatized with BA, BA+DPE, and 
BA+DPE+gly. 
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Figure 2-20. BA/Epi product spectra in deuterated chloroform.  1H NMR δ 8.2 (2H, m), 7.6 (1H, t, J = 0.7 Hz), 7.5 (3H, 
m), 6.6 (1H, s), 5.3 (1H, dd, J = 3), 4.5 (1H, dd, J = 5.8), 3.5 (2H, m), 2.8 (3H, s). 
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Figure 2-21. BA/DPE Product NMR Spectra. NMR Solvent DMSO. 1H NMR (CDCl3)  δ 8.1 (2H, m), 7.55 (3H, tdd), 7.35 
(1H, s), 6.9 (1H, s), 5.1 (2H, s), 2.2 (3H, s). 
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Figure 2-22. 5HI/BA Product Spectra. NMR Solvent DMSO. 1H NMR (CDCl3) δ 9.2 (1H, s), 8.35 (2H, m), 7.75 (1H, dd, J 
= 2.15 Hz, J = 0.95 Hz), 7.65 (1H, d, J =  8.85 Hz), 7.55 (3H, m), 7.45 (1H, dd, J = 9.0 Hz, J = 1.0 Hz),  4.45 (2H, q, J = 4.60 
Hz), 1.5 (3H, t, 7.15 Hz). 
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Chapter 3 
Synthetic Approaches Towards Improving 
Existing Derivatization Reagents  
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3.1 Introduction 
3.1.1 General Goals of Derivatization 
The goal of derivatization is to improve the detectability of an analyte through chemical 
modification. More broadly, the focus is to improve solubility, stability, chromatographic properties, and 
sensitivity at the time of detection for the analyte of interest[1]. In order to assess the importance of 
each of these attributes they should first be considered individually. Solubility can be a concern within 
the context of amino acid and peptide derivatization as there is a need for water-soluble derivatization 
reagents that can produce water soluble products. In turn, this concern can be extended towards 
chromatographic performance as hydrophobic products within a sample can result in chromatographic 
challenges.  Typically, when groups of analytes exhibit physical properties that are extremely hydrophilic 
or hydrophobic, it is challenging to produce an acceptable separation. Chromatographic property 
concerns can further be extended towards the goal of sample cleanup as inclusion of a tag for sample 
enrichment and purification via affinity chromatography is a common goal for derivatization[2].  
Stability is important both for derivatization reagent and derivatization product relevant to the 
time scale within the reaction time and detection time. Finally, the derivatization reagent should carry 
properties that enhance sensitivity at the time of product analysis, whether this involves functional 
groups, which can enhance ionization during mass spectrometry analysis, or produce a product, which 
can be measured using sensitive methods such as fluorescence that has inherently low limits of 
detection. With those objectives in mind, creating a reagent that not only accomplishes those goals, but 
also is uniquely reactive towards the analyte and produces a product in high yields, can provide a unique 
analytical challenge.  
3.1.2 Derivatization Reagents for Protein-Bound 3-Nitrotyrosine 
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An early approach towards derivatization of protein-bound 3-nitrotyrosine focused on using a 
reagent containing a biotin tag [3]. The Tannenbaum strategy, which serves as a starting point for all 
derivatization strategies for protein bound 3-nitrotyrosine derivatizations, begins by reduction of the 
nitro group on tyrosine to an amine in order to create a reactive site for derivatization. After chemically 
modifying the newly formed amine by covalently attaching the biotin reagent, the tag served as a means 
for sample purification and enrichment through capture on streptavidin beads. The biotin reagent was 
the first exhibiting desired attributes for 3-nitrotyrosine derivatization, namely sensitivity through 
enrichment. However, as it depended upon pH control as a means of achieving selectivity, its ability to 
successfully enrich 3-nitrotyrosine from a biological matrix has been dismissed[4]. In a similar approach, 
Zhang et al. reported the successful derivatization of 3-nitrotyrosine using NHS S-acetylthioacetate[5]. 
The disadvantage of their methodology lies in the required sample preparation in which peptides were 
acetylated prior to nitro reduction in order to mask reactive amines. While this approach was successful 
in achieving selectivity by masking non-target amines, a reagent which imparts selectivity independent 
of sample preparation is inherently more valuable[6]. 
Within the scope of the current project, the goal was to build upon previously described work to 
produce a derivatization reagent that can be used to enhance detection of protein-bound 3-
nitrotyrosine through HPLC coupled with either fluorescence detection or MS detection.  To accomplish 
these objectives, our approach is to enhance existing derivatization reagents through structural 
modification. The reactions we are seeking to enhance are the derivatization reactions of pro-quinones 
by either BA or DPE. As benzylamine is structurally simpler, it was the focus of our initial attempts at 
modification. Although benzylamine itself is a water soluble compound, the product that results from its 
use in derivatization exhibits a high degree of hydrophobicity. While derivatizations described within this 
work occur on analytes dilute enough for the product solubility to not be an issue, we sought to create a 
more hydrophilic product to affect chromatographic properties during analysis. We also plan to include 
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a stable functional group on the reagent that can be used as a handle for either affinity chromatography, 
or ion exchange chromatography for the purpose of analyte purification and enrichment. Finally, we 
plan to create DPE based reagents that mirror the properties imparted to the BA counterparts. 
3.2  Materials and Methods 
3.2.1 Chemicals and Reagents 
 1R,2R-Diphenylethylenediamine, meso-1,2-diphenylethylenediamine,benzil, salicylaldehyde, 
ammonium hydroxide, acetic anhydride, 4-(dimethlamino)benzaldehyde, maleic anhydride, p-
bromoaniline, ruthenium chloride, sodium metaperiodate, sodium thiosulfate, sodium chloride, 
magnesium sulfate, manganese perchlorate, pyridine-2-carboxylic acid, dioxane, 50% hydrogen 
peroxide, sodium acetate, sodium bisulfite, 2,2-dimethoxypropane, p-toluenesulfonic acid, cyclohexane, 
and meso-1,2-bis(2-hydroxyphenyl)ethylenediamine were purchased from Sigma Aldrich (St. Louis, MO). 
Tetrahydrofuran, ethyl acetate, hexanes, acetone, acetonitrile, benzene, chloroform, methylene 
chloride, and ethanol were purchased from Fisher Scientific (Waltham, MA). 
3.2.2 Instrumentation 
 All NMR Spectra were obtained on a Bruker (Billerica, MA) Avance 400 MHz spectrometer. HPLC 
data was obtained on a Shimadzu (Kyoto, Japan) LC-10 series HPLC consisting of an SLC-10A vp system 
controller, two LC-10AD vp pumps, an SIL-10AD vp  auto-injector and a SPD-10A vp UV detector. Mass 
spectra was recorded on a Waters (Milford, MA) MICROMASS QUATTRO micro triple quadrupole mass 
spectrometer.  
 Chromatographic separations to determine purity of synthetic products were carried out using a 
phenomenex (Torrance, CA) column measuring 150 x 4.6 mm packed with Inertsil 5 µm ODS-3 100 A 
particles. Mobile phase A was composed of 90:10 water:methanol with 0.1% formic acid and mobile 
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phase B was composed of 10:90 water:methanol with 0.1% formic acid. A gradient elution program was 
applied consisting of a linear change from 0% B to 100% B over 10 minutes, followed by holding 100% B 
for 7 minutes. The column was equilibrated for 7 minutes prior to an injection. 
 Preparative scale chromatography for isolation of sulfonic acid analogs was performed on a 
phenomenex 250 x 10 mm column packed with 10 µm LUNA ODS-3 particles. The mobile phase 
consisted of 20 mM ammonium bicarbonate buffer in water. The column was washed with for 10 
minutes using a linear gradient program from 0 to 100% B with a mobile phase of 0.1% formic acid in 
water for mobile phase A and 0.1% formic acid in methanol for mobile phase B between injections. 
3.2.3  Sulfonic Acid Modification 
4-(Aminomethyl)benzenesulfonic acid (ABS). ABS was synthesized according to a previously 
published procedure[7]. To a 100 mL round bottom flask, 30 mL of oleum was added with a magnetic stir 
bar. The liquid was cooled 0°C on an ice bath upon which 10 mL of benzylamine was slowly added. After 
the addition was completed, the solution was removed from the ice bath, allowed to warm to room 
temperature, and then heated to 80°C on a water bath. After stirring for an hour, the solution was 
allowed to cool to room temperature and was subsequently poured into 300 mL of dioxane. The 
precipitate that forms is collected by suction filtration through a paper pad in a Buchner funnel and is 
washed with 50 mL addition dioxane. The collected solid is dissolved in a minimal amount of ammonium 
hydroxide. Slow and careful addition of concentrated hydrochloric acid affords 5 grams of product as a 
white precipitate.  
3,3'-(1,2-diaminoethane-1,2-diyl)dibenzenesulfonic acid (DPE-SA). DPE-SA was synthesized 
according to previously published procedures[8] with slight modifications. Five grams of (1R,2R)-1,2-
diphenylethane-1,2-diamine are slowly added to 25 mL of fuming sulfuric acid in a 100 mL round bottom 
flask equipped with a magnetic stir bar. The solution is heated to 100° C for 3 hours while stirring. After 
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cooling, the solution is cautiously added to 150 mL of cool THF. The product precipitates as a mixture of 
isomers which is isolated by filtration. Isomers are separated on a phenomenex Luna 10 µm-PREP C18(2) 
column measuring 250 x 21.20 mm using a 20 mM ammonium bicarbonate mobile phase. Solvent was 
removed from the collected product fraction by rotary evaporation leaving a white solid. 1H NMR δ 7.5 
(4H, m), 7.2 (4H, m), 4.3 (2H, m) (Figures 5 and 21). 
3.2.4  Meso-1,2-bis(2-hydroxyphenyl)ethylenediamine (HPED) 
 The following syntheses for the formation of HPED were reproduced from previously published 
procedures by Vogtle and Goldschmitt[9] with minor variations throughout (Figure 3-2). 
 N,N'-((1R,2S)-1,2-bis(2-hydroxyphenyl)ethane-1,2-diyl)dibenzamide. In a 250 mL 3-necked 
round-bottom flask, 1.05 g of benzil was added to 1.06 mL of salicylaldehyde dissolved in 75 mL of 
ethanol. The flask was equipped with a condenser, a dropping flask, and a thermometer.  One (1) mL of 
ammonium hydroxide dissolved in 20 mL of ethanol is added to the dropping funnel. The ammonium 
hydroxide solution is added over one hour. The solution was then heated to reflux and allowed to cool 
after 3 hours. The product crystallizes as a yellow powder and used without further purification in the 
next step. TLC analysis using a 75:25 ethyl acetate:hexanes produces a spot with an Rf of 0.8. 
1H NMR δ 
10.0 (2H, s), 8.6 (2H, d, J = 8.6), 7.6 (4H, m), 7.5 (8H, m), 7.0 (2H, m), 6.8 (4H, m), 5.9 (2H, s) (Figure 3-6). 
((1R,2S)-1,2-diacetamidoethane-1,2-diyl)bis(2,1-phenylene) diacetate. Ninety (90) grams of 
N,N'-((1R,2S)-1,2-bis(2-hydroxyphenyl)ethane-1,2-diyl)dibenzamide from the previous reaction are 
suspended in 250 mL of acetic anhydride in a 500 mL round bottom flask. A magnetic stir bar is added 
and the suspension is equipped with a condenser. The suspension is heated to reflux for 24 hours upon 
which it will turn dark brown and then black. Upon cooling, the product crystallizes as a white powder. 
The product is isolated by filtration and washed with additional acetic anhydride (40% yield) and used 
immediately in the next step. 
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1,2-bis(2-hydroxyphenyl)ethylenediamine. Thirty (30 g) of ((1R,2S)-1,2-diacetamidoethane-1,2-
diyl)bis(2,1-phenylene) diacetate is suspended in a 1:1 solution of 48% hydrobromic acid: glacial acetic 
acid in a 250 mL round bottom flask. The flask is equipped with a condenser and heated to 90° C for 3 
hours. After the solution is allowed to cool to room temperature, the solid is collected by filtration and 
dissolved into 200 mL of warm water. The solution is brought to neutral pH by 20% sodium hydroxide 
and a flaky white solid precipitates as the product. The product is recrystallized from either acetonitrile 
or benzene. Melting point 184-186 °C. 1H NMR δ 7.3 (2H,m), 7.2 (2H, m), 6.9 (4H, m), 4.3 (1H, s) (Figure 
3-7). 13C NMR δ 129.8 (2C, d), 119.3 (1C, s), 118.0 (1C, s), 59.2 (1C, s) (Figure 3-8). MS (M+1) 245 (Figure 
3-9). 
3.2.5  Dimethylamine Modification 
1,2-bis(4-(dimethylamino)phenyl)ethane-1,2-diamine (DMA-DPE) synthesis was reproduced 
from previously published procedures[10] (Figure 3-3). 
2,2'-((1E,1'E)-((1,2-bis(4-(dimethylamino)phenyl)ethane-1,2-
diyl)bis(azanylylidene))bis(methanylylidene))diphenol. Meso-1,2-bis(2-hydroxyphenyl)ethylenediamine 
(2.2 g) is suspended in 33 mL of ethanol in a 100 mL round bottom flask. The flask was equipped with a 
magnetic stir bar and 3.5 g of 4-(dimethylamino)benzaldehyde was slowly added to the suspension upon 
stirring. Within 30-60 minutes the suspension slowly turns clear. The solution is stirred for an additional 
3 hours upon which the product slowly crystallizes as a yellow solid which is dried in an oven at 60 °C 
and subsequently used without further purification. 
1,2-bis(4-(dimethylamino)phenyl)ethane-1,2-diamine. 2.5 grams of 2,2'-((1E,1'E)-((1,2-bis(4-
(dimethylamino)phenyl)ethane-1,2-diyl)bis(azanylylidene))bis(methanylylidene))diphenol from the 
previous reaction were dissolved in 100 mL of THF in a 250 mL round bottom flask. The solution was 
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stirred vigorously as 3 mL of concentrated hydrochloric acid were slowly added. A white precipitate 
forms upon addition of the acid producing the product as a dihydrochloride salt. 
3.2.6  Cis-Diol Functionalized Pyrrolidines 
 (3R,4S)-1-(4-bromophenyl)-3,4-dihydroxypyrrolidine-2,5-dione via tartaric acid. This synthesis 
was reproduced from previously published procedures with minor deviations[11].  To a 250 mL round 
bottom flask was added 2 g of meso-tartaric acid followed by 100 mL of xylenes. 2 g of p-bromoaniline 
was added and flask was equipped with a Dean-Stark apparatus. The solution was then heated to reflux 
until the reaction was complete (approx. 10 hours). Upon cooling, the product precipitates and is 
collected by filtration. The product is recrystallized from ethanol. 
N-(4-bromophenyl) maleanilic acid[12]. In a 250 mL round bottom flask equipped with a reflux 
condenser, 18 g of maleic anhydride are dissolved into 150 mL of MTBE. To this, 31 g of 4-bromoaniline 
dissolved in 60 mL of MTBE are added over 30 min. After stirring the solution for an additional hour a 
white solid crystallizes. The solid maleanilic acid is collected by filtration, washed with 10 mL of MTBE 
and used in the next step without further purification. 1H NMR δ 13.0 (1H, s), 10.5 (1H,s), 7.6 (2H, d, J = 
8.7), 7.5(2H, d, J = 8.7), 6.5 (2H, d, J = 12), 6.3 (2H, d, J = 12) (Figure 3-10) 
N-(4-bromophenyl) maleimide [12]. In a 50 mL round bottom flask, 0.8 g of anhydrous sodium 
acetate was added to 20 mL of acetic anhydride. 5g of N-(4-bromophenyl maleanilic acid are added and 
the suspension is swirled on a steam bath for an hour resulting in a clear solution. The solution is cooled 
on an ice bath and 40 mL of cold water is added upon which yellow needles crystallize. The product is 
collected by filtration and dried in a vacuum oven at 40 °C. (Figure 3- 14) 1H NMR δ 7.7 (2H, m), 7.3(2H, 
m), 7.2 (2H, s) (Figures 11, 14) 
68 
 
 Meso-N-(4-bromophenyl)-3,4-dihydroxy-2,5-pyrrolidinedione via ruthenium catalyzed 
hydroxylation. The following ruthenium catalyzed hydroxylation reaction was reproduced from a 
publication by Couturier[13].To a stirred solution of 0.020 g of ruthenium chloride hydrate in 10 mL of 
water was added a solution of 2 g N-(4-bromophenyl)maleimide dissolved in 5 mL ethyl acetate and 5 
mL acetonitrile. The solution is cooled to 0° C and then 12 equal portions of 0.25 g sodium periodate 
were added to the solution. The slurry was allowed to cool between additions. Upon reaction 
completion, the slurry was quenched with a solution of 1.8 g sodium thiosulfate dissolved in 5 mL water. 
The slurry was filtered to remove solids and the solids were rinsed with 5 mL of ethyl acetate. The 
filtrate was transferred to a separation funnel and after the organic and aqueous layers separate, the 
aqueous layer was discarded. The organic layer was washed three times with a 2 M sodium chloride 
solution. After washing, the organic was dried with magnesium sulfate and concentrated by rotary 
evaporation to 1 mL. The flask was then cooled to 5° C and 5 mL of hexanes were added. The product 
crystallized as a white solid. 1H NMR δ 7.7 (2H, m), 7.2(2H, m), 6.1 (2H, s), 4.5 (2H, s) (Figure 3-12, 15) 
Meso-N-(4-bromophenyl)-3,4-dihydroxy-2,5-pyrrolidinedione via manganese catalyzed 
hydroxylation. The following manganese catalyzed hydroxylation was reproduced from previous 
published work by Saisaha et al[14]. In a 100 mL round bottom flask equipped with a magnetic stir bar, 
0.03 g of manganese perchlorate, 0.03 g of pyridine 2-carboxylic acid and 2 g of N-(4-
bromophenyl)maleimide are dissolved into 25 mL of acetone and cooled to 0° C. 167 µL of 6 M sodium 
acetate are added followed immediately by 1 mL of 50% hydrogen peroxide solution. The mixture is 
allowed to warm to room temperature and stirred for an additional 16 hours. Sodium bisulfite is added 
to the solution until excess peroxide is destroyed (checked by peroxide strip indicator). The suspension 
is filtered and solvent is removed by rotary evaporation producing the product as a white solid. (Figure 
3-17)  
69 
 
(3aR,6aS)-5-(4-bromophenyl)-2,2-dimethyldihydro-4H-[1,3]dioxolo[4,5-c]pyrrole-4,6(5H)-
dione[15]. To a 100 mL dry round bottom flask under argon is added 2 g of Meso-N-(4-bromophenyl)-3,4-
dihydroxy-2,5-pyrrolidinedione from the previous reaction and a magnetic stirring bar. 25 mL of 2,2-
dimethoxypropane, 25 mL of cyclohexane, and 0.1 g of p-toluenesulfonic acid are added and the flask is 
equipped with a dry vigruex column attached to a dry condenser and receiving flask. The mixture is 
heated to reflux to remove azeotropes and the solution will turn a dark red. The solution is kept under 
argon and heat for 1-2 days until the reaction reaches completion as checked by HPLC. (Figure 3-18) 1H 
NMR δ 7.7 (2H, m), 7.3(2H, m), 5.1 (2H, s), 1.47 (6H, d, J = 3.8) (Figure 3-13) 
(3aR,6aS)-5-(4-bromophenyl)-2,2-dimethyltetrahydro-4H-[1,3]dioxolo[4,5-c]pyrrole via 
Lithium Aluminum Hydride Reduction[11]. All glassware for this reaction was dried in an oven at 150°C 
for at least 24 hours prior to reaction and the reaction was kept under argon until workup. To a 250 mL 
round bottom flask was added 100 mL of dry THF under a stream of argon. 0.3 g of (3aR,6aS)-5-(4-
bromophenyl)-2,2-dimethyldihydro-4H-[1,3]dioxolo[4,5-c]pyrrole-4,6(5H)-dione from the previous 
reaction was dissolved and the solution was cooled on an ice bath.  0.1 g of lithium aluminum hydride 
was added in small portions to the reaction. The flask was equipped with a reflux condenser and was 
heated to reflux for 24 hours while stirring. After the solution was allowed to cool, the vessel was placed 
on an ice bath and sequential additions of water (2 mL), 15% NaOH (2 mL), and water (6 mL) were 
added. The solution was extracted with ethyl acetate and the solvent evaporated. The resultant residue 
was analyzed by HPLC-UV showing severe product degradation (Figure 3-19). 
(3aR,6aS)-5-(4-bromophenyl)-2,2-dimethyltetrahydro-4H-[1,3]dioxolo[4,5-c]pyrrole via 
NaBH4/I2
[16]. All glassware for this reaction was dried in an oven at 150°C for 24 hours prior to use. To a 
250 mL round bottom flask under argon is added 0.3 g of (3aR,6aS)-5-(4-bromophenyl)-2,2-
dimethyldihydro-4H-[1,3]dioxolo[4,5-c]pyrrole-4,6(5H)-dione dissolved in 30 mL of dry THF. 0.3 g of 
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NaBH4 is added under an argon stream. The solution is stirred and put on an ice bath and 0.2 g of 
starting material is added. The flask is equipped with a dropping funnel and 0.5 g of I2 dissolved in 30 mL 
of dry THF are added over 30 minutes. The flask is then equipped with a reflux condenser and the 
solution is refluxed for over 18 hours. After the solution is allowed to cool, 5 mL of methanol is 
cautiously added. As HPLC-UV analysis shows a chromatogram more complicated than expected, the 
solution was not worked up. 
3.3  Results and Discussion 
3.3.1  Sulfonic Acid Modification of Benzylamine and Diphenylethylenediamine 
 In order to achieve a reagent that fulfills the previously described objectives, we sought to 
create modified versions of BA and DPE, which possesses a sulfonic acid substituent. p-
Aminomethylbenzene sulfonic acid (ABS) was a relatively easy reagent to produce using slightly 
modified procedures which have previously been published. Sharov et al. have shown that this reagent 
accomplishes many of the goals we had hoped to accomplish with reagent modification[7]. Chief among 
these goals were the additional hydrophilicity the sulfonic acid adds to the product upon completion of 
derivatization and a longer stokes shift seen in the product fluorescence. In addition, we also show how 
it can be used for analyte purification using the sulfonic acid as an affinity handle for ion exchange 
chromatography (see chapter 4). Due to its ease of acquisition and utility in derivatization reactions, we 
sought to produce a similar analog based upon DPE.   
 The approach to create a sulfonic acid modified DPE was expected to be as straight forward as 
ABS synthesis (Figure 3-1). However, a publication from 2013 revealed a series of isomers is created 
when DPE is heated in fuming sulfuric acid[8]. Moreover, this series of isomers has the potential to create 
a needlessly complicated product distribution when used for derivatization. The same publication 
provided a means of product purification (detailed description of a preparative HPLC column and mobile 
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phase) that were not reproducible in our laboratories. Their methodology utilized an isocratic separation 
by preparative HPLC using a 20 mM potassium chloride mobile phase on a Varian Dynamax column 
measuring 250 X 10 mm. No further information was reported in that publication about particle 
dimensions, mobile phase velocity, or injection size. Through discussions with technical personnel from 
Agilent (Varian products were acquired by Agilent in 2009) the 5µm Zorbax C18 phase was claimed to be 
the same phase as previously supplied by Varian.  As a result the Agilent preparative column (9.4 mm x 
250 mm) was acquired for purification of the sulfonated DPE product mixture.  Unfortunately baseline 
resolution of the three isomers could not be achieved with the so-called equivalent phase.  Examination 
of other phases next turned to the evaluation of a Phenomenex Luna 10 µm-PREP C18(2) column 
measuring 250 x 21.20 mm. The Luna column did not resolve the two minor product isomers, but 
provided baseline resolution of the major product isomer we sought to isolate (Figure 3-20). As the 
different column provided a means of product isolation, it was used in subsequent separations with 
further modifications to chromatographic conditions.  
During testing of column selectivity, we decided to see if diamine stereochemistry was 
important to the separation. To test this, we conducted the sulfonation reaction with S,S-1,2-
diphenylethylenediamine, and then separately with meso-1,2-diphenylethylenediamine. Previous work 
had shown that diamine stereochemistry did not affect the derivatization reaction. There was an 
interest to see if meso-1,2-diphenylethylenediamine could be used instead of the published S,S-1,2-
diphenylethylenediamine as the meso isomer is only 25% the cost of the S,S isomer. By using a cheaper 
version, we could accomplish our goal of producing higher quantities of the reagent in a cost efficient 
manner. Unfortunately, the product mixture obtained from sulfonation of the meso-diamine exhibited a 
much different separation selectivity than those of the other optical isomer, which was used in the 
previously noted publication, so efforts utilizing it were halted. 
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 The next obstacle to overcome with regards to DPE-SA purification arose due to the nature of 
the isomer separation. The published method utilized a 20 mM KCl mobile phase. Upon collection of the 
desired isomer and subsequent solvent evaporation, the resulting solid consisted of a majority salt with 
a minor amount of desired sulfonic acid. To find an easy way to desalt the collected isomer, we 
hypothesized that an SPE separation could provide an easy means of capturing the product while 
washing away the salt. A phenomenex Strata X-AW 33 µm polymeric weak anion exchange cartridge was 
used to see if the product could be easily purified through anion exchange. Initial attempts failed to 
retain the product within the salty solvent composition.  
In tandem with testing purification by extraction, we also hypothesized that the purification 
could proceed in a much easier fashion if there was a way to remove the high salt content from the 
chromatography. During test separations involving different mixtures of water, methanol, and 
acetonitrile as mobile phases, it became rapidly apparent that separation of the different isomers was 
dependent upon the presence of the potassium chloride. With the need for salt to achieve separation, it 
was then hypothesized that if the salt content was switched from a non-volatile mobile-phase additive 
to a salt that could be evaporated during subsequent solvent removal, the isomer purification could be 
completed in a one-step separation. Towards this end, the 20 mM potassium chloride mobile phase was 
exchanged for a 20 mM ammonium bicarbonate mobile phase (Figure 3-21) which achieved the goal of 
separating the different isomers using a volatile buffer providing pure reagent for use in derivatization. 
3.3.2 Dimethylamine Modification of BA and DPE 
 During our work producing sulfonic acid modified derivatization reagents, we also sought to 
elaborate the base structure of BA and DPE by providing a basic substituent. Addition of a 
dimethylamino-substituent to the derivatization reagents fit the profile of a functional group that would 
accomplish these goals along with the objectives we sought to accomplish for general derivatization 
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reagent previously described. It was proposed that a tertiary amine could be used as an affinity handle, 
would aid in ionization during mass spectrometry analysis, and would influence fluorescence emission. 
Fortunately, p-dimethylaminobenzylamine (DMA-BA) was commercially available and did not require 
synthesis. A DPE analog was not commercially available and required synthesis. 
 A 2008 publication which describes the creation of functionalized DPE analogs reported the 
synthesis of the desired 1,2-bis(4-(dimethylamino)phenyl)ethylenediamine (DMA-DPE) (Figure 3-3). Such 
synthesis required benzaldehyde with the desired functional group modification and 1,2-bis(2-
hydroxyphenyl)ethylenediamine (2HPED) that is used as a templating reagent for creation of new  DPE 
analogs[10]. The required starting materials,  benzaldehyde for DMA-DPE synthesis and 2HPED, are 
commercially available; however, 2HPED is used as a starting material for synthesis of certain cisplatin[17] 
anticancer drugs, and it was found to be both expensive and frequently of limited supply.  To address 
these issues, its preparation was undertaken. 
 The synthesis of 2HPED was first reported in an 1884 publication by Japp and Hooker[18]. The 
reaction involves benzil in the presence of ammonium hydroxide and salicylaldehyde to form an 
intermediate diimine. This complex rapidly undergoes a diazo-Cope rearrangement as characterized by 
Vogtle and Goldschmitt[9]. Subsequent acetylation of both the alcohols and amines creates a tetra-acetyl 
compound, which was hydrolyzed using strong acid at high temperature (Figure 3-2), to provide the 
desired meso-2HPED, the critical template for the preparation of various DPE analogs. In the present 
case, 2HPED was used for preparation of DMA-DPE.  
As meso-2HPED was the most straightforward template diamine to prepare, it was used in 
subsequent diazo-cope rearrangements and caused the synthesis of the desired DMA-DPE to proceed 
slowly, as compared to the previously noted required reaction times. The reference procedure used R,R-
HPED as opposed the meso isomer we produced. Previous publications from the same group confirmed 
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that the meso isomer undergoes rearrangement up to 30 times slower. The reason for this is the R,R 
isomer is “pre-organized” so that its transition state can more easily form hydrogen bonds between the 
phenolic hydrogens and bridging amines that aid in driving the reaction towards completion[19]. 
Subsequently, we altered the reaction times of the critical steps (aided by monitoring reaction progress 
by HPLC) and developed appropriate overall procedures for the synthesis and obtained the desired 
DMA-DPE product. Of note,  shortly after our successful synthesis of the meso-DMADPE, the R,R-
DMADPE became commercially available, thus mitigating against the need for further synthesis of this 
particular product. 
3.3.3  Cis-diol Functional Group as a Desired Analog 
 Following the successful synthesis of DMA-DPE, steps were taken to produce a DPE analog that 
possessed a cis-diol functional group. Incorporation of this specific functional group not only imparts 
needed hydrophilicity onto DPE but also has been shown to be valuable as an affinity handle for 
boronate affinity chromatography. A BA version of this derivatization reagent, which incorporated a cis-
diol attached through a pyrrolidine ring, had been successfully synthesized and used for 3-nitrotyrosine 
purification, enrichment, and analysis [20]. 
 Our approach in synthesizing a DPE based derivatization reagent that incorporated a cis-diol was 
the same approach used for synthesizing DMA-DPE, except in place of the simple tertiary amine, we 
sought to replace the dimethylamine with a pyrrolidine ring containing a cis-diol. To achieve this, we 
sought to create 4-((3S,4R)-3,4-dihydroxypyrrolidin-1-yl)benzaldehyde. We could then use the newly 
created benzaldehyde in the previously described diaza-cope rearrangement to produce the desired cis-
diol-DPE (Figure 3-4). 
 Our first priority in producing the desired benzaldehyde was a facile way of generating a cis-diol 
substituted pyrrolidine. In what appeared to be an easy way to accomplish this goal, we pursued the 
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reaction of aniline with meso-tartaric acid in xylenes at elevated temperatures following a related 
preparation which used benzylamine instead of aniline[21]. While this reaction successfully generates the 
expected cis-diol pyrrolidine dione, at the high temperatures necessary to generate the pyrrolidine 
dione, the diol found on meso-tartaric acid racemizes creating a mixture of the desired cis-diol and an 
undesired trans-diol. As this finding is supported by literature[22], a different approach was explored for 
cis-diol formation. 
 In order to generate the pure cis-diol pyrrolidine dione, an approach similar to previously 
synthesized pyrrollidine diol derivatization reagents was used [20]. This involved the well-established 
formation of N-phenyl maleimide[12] followed by oxidation to create the desired cis-diol. In an effort to 
avoid the use of highly toxic osmium tetroxide, which had been previously  used for the formation of the 
cis-diol, ruthenium chloride was first used for oxidation as it had been well established as a means to 
generate the desired diol stereochemistry[13]. While we were successful in synthesis of the desired cis-
diol pyrrolidine dione, the reaction was not reliably reproducible. The main issue with the reaction is the 
need to control reaction temperature. The reference procedure used cautioned against allowing the 
temperature to rise above 5° C, as this can lead to over-oxidation and oxidative scission[23]. We found 
that over-oxidation occurs when the temperature rises above 0 °C (Figures 15, 16). An alternative cis-
hydroxylation procedure that uses manganese as a catalyst in the presence of hydrogen peroxide[14] was 
chosen as a superior route, as it not only avoids the previously encountered problems with over-
oxidation (Figure 3-17), but avoids tedious cleanup of periodate salts generated in the ruthenium 
chloride reaction. 
 The next step in producing the desired benzaldehyde was the reduction of acquired pyrrolidine 
dione to pyrrolidine. It has been reported that reduction of pyrrolidine dione can be accomplished by 
using lithium aluminum hydride[11]. Problems with this approach became readily apparent while the 
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reaction was monitored. In several attempts to effect the reduction, it was found that several side 
products were generated (Figure 3-18). While such reductions have previously been reported as 
successful, a critical review of the literature reveals that for this particular substrate type that undesired 
side products are frequently encountered[11, 24]. In an effort to avoid side product formation, we 
attempted to reduce the n-phenylpyrrolidinedione with sodium borohydride in the presence of iodine. 
This approach was based on prior successful reports of very similar substrates. Although the reaction 
proceeded in a cleaner fashion than the previously explored lithium aluminum hydride reaction, side 
product generation was still an issue, as reductive cleavage of carbon-carbon bonds is reported as a 
problem with this route of reduction [25]. As considerable effort had been put forth to produce cis-diol 
pyrrolidine benzaldehyde without success, efforts were redirected towards development of other 
successfully synthesized derivatization reagents and pyrrolidinedione reduction was no longer pursued. 
3.4 Conclusions 
The goal of the current work was creation of novel derivatization reagents through synthetic 
modification of existing derivatization reagents in an effort to improve solubility, stability, 
chromatographic properties, and sensitivity at the time of detection. BA and DPE provided the base 
reagents for modification. The attempted modifications included addition of sulfonic acid, addition of a 
tertiary amine, and addition of a cis-diol.  
Addition of sulfonic acid to BA to produce ABS had been previously accomplished. The same 
approach was used to successfully produce the sulfonic acid modified DPE and the product was purified 
for use by preperative chromatography. Acquisition of BA and DPE modified by addition of a tertiary 
amine was accomplished as the desired DMA-BA was commercially available and published procedures 
to produce DMA-DPE via diaza-cope rearrangement were successfully utilized within our lab. Several 
different approaches to synthesize a DPE modified by addition of a cis-diol were taken. The 
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condensation reaction between meso-tartaric acid and aniline was found to produce an unusable 
racemic mixture. While two different oxidative approaches at cis-diol synthesis were successful, 
subsequent attempts at pyrrolodinedione reduction through utilization of both lithium aluminum 
hydride and sodium borohydride were not successful which halted any further pursuits of cis-diol 
modified DPE.  
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3.5 Chapter 3 Figures 
 
 
Figure 3-1. Reaction scheme showing distribution of isomers that result from the reaction of DPE with fuming sulfuric acid. 
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Figure 3-2. Reaction scheme used for the synthesis of template diamine 2HPED
[9]
. 
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Figure 3-3. Diaza-Cope rearrangement utilizing p-dimethylaminobenzaldehyde to synthesize DMA-BA
[10]
. 
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Figure 3-4. Proposed synthetic scheme for creation of a novel DPE analog from N-(p-bromophenyl)maleimide which 
incorporates a cis-diol functional group attached through a pyrrolidine ring. 
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Figure 3-5. 
1
H NMR spectra for DPE-SA. 
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Figure 3-6. 
1
H NMR Spectra for N,N'-(1,2-bis(2-hydroxyphenyl)ethane-1,2-diyl)dibenzamide. 
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Figure 3-7. 
1
H NMR for 1,2-bis(2-hydroxyphenyl)ethylenediamine 
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Figure 3-8. 
13
C NMR for 1,2-bis(2-hydroxyphenyl)ethylenediamine.  
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Figure 3-9. Mass spectra scan from 240 amu’s to 250 amu’s showing (M+1) for 1,2-bis(2-hydroxyphenyl)ethylenediamine. 
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Figure 3-10. 
1
H NMR for N-(4-bromophenyl)maleinilic acid. 
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Figure 3-11. 
1
H NMR for N-(4-bromophenyl)maleimide. 
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Figure 3-12. 
1
H NMR for meso-n-phenyl-3,4-dihydroxy-2,5-pyrrolidinedione. 
  
90 
 
 
Figure 3-13. 
1
H NMR for (3aR,6aS)-5-(4-bromophenyl)-2,2-dimethyldihydro-4H-[1,3]dioxolo[4,5-c]pyrrole-4,6(5H)-dione 
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Figure 3-14. HPLC-UV chromatogram showing 99% purity for N-(4-bromophenyl)maleimide. 
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Figure 3-15. Reaction products from the ruthenium catalyzed hydroxylation reaction showing meso-n-phenyl-3,4-dihydroxy-
2,5-pyrrolidinedione eluting at 8.9 min with side product from over oxidation showing at 9.8 min. 
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Figure 3-16. Ruthenium catalyzed hydroxylation showing over oxidized product from the ruthenium hydroxide catalyzed 
oxidation of N-(4-bromophenyl)maleimide which occurs when temperature rises above 0°C. 
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Figure 3-17. Product from the manganese catalyzed hydroxylation reaction showing product meso-n-phenyl-3,4-dihydroxy-
2,5-pyrrolidinedione exhibiting 96% purity. 
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Figure 3-18. Pure (3aR,6aS)-5-(4-bromophenyl)-2,2-dimethyldihydro-4H-[1,3]dioxolo[4,5-c]pyrrole-4,6(5H)-dione product 
from the cis=diol protection reaction. 
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Figure 3-19. HPLC-UV chromatogram of the solid residue produced from the lithium aluminum hydride reduction of 
(3aR,6aS)-5-(4-bromophenyl)-2,2-dimethyldihydro-4H-[1,3]dioxolo[4,5-c]pyrrole-4,6(5H)-dione. 
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Figure 20. Separation of DPE-SA isomers on a phenomenex Luna 10 µm C18-2 250 X 21.20 mm column 
using 20 mM KCl mobile phase DPE with fuming sulfuric acid.  
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Figure 3-21. HPLC-UV chromatogram showing baseline resolution of all three isomers resultant from the reaction of DPE in 
fuming sulfuric acid on a phenomenex Luna 10 µm C18-2 250 X 21.20 mm column using 20 mM ammonium bicarbonate 
buffered mobile phase of which the major peak was collected for future derivatization reactions. 
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Chapter 4 
Comparison of Derivatization Reagent Analogs towards  
Protein-Bound 3-Nitrotyrosine Analysis 
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4.1  Introduction 
4.1.1  Protein Bound 3-Nitrotyrosine as an Analytical Target 
Protein bound 3-nitrotyrosine (P3NY) is a post-translation modification that results from 
nitroxidative stress. Its formation and accumulation have been related to several age related diseases 
such as cancer, Parkinson’s, and ALS[1]. As this specific modification is an established biomarker of said 
disease states, analytical strategies which take advantage of this knowledge for diagnostic purposes are 
just becoming available. Additionally, while P3NY has been shown to form through several different 
nitrosative pathways, the protein structural features that are responsible for increased susceptibility to 
nitration have not been conclusively defined[2].  
Analysis of P3NY is complicated by several factors. First among these is the low abundance of 
the modification. With respect to plasma proteins subjected to inflammatory conditions, approximately 
one in 10,000 tyrosine residues are nitrated [3]. Within the context that tyrosine residues constitute only 
three to four molar percent of proteins[2], any technique that attempts P3NY detection needs to exhibit 
inherently low detection limits. The sample matrix further complicates the challenge of low abundance 
determinations of 3NY. Analysis of biological tissues requires expertise beyond standard analytical 
techniques[4]. Favored methodology for identification of post-translational modifications involves 
protein isolation, protein digestion, and detection by LC-MS/MS. However, within the field of 
proteomics, robust methodologies for analysis of P3NY do not exist. In order to better understand the 
nature of P3NY formation, and more importantly what conditions lead to formation in vivo, better 
analytical strategies need to be developed. Such strategies must have low limits of detection, specificity 
towards the analyte, and compatibility towards the matrix where the analyte resides. These 
requirements can be met through chemical derivatization, post-derivatization extraction for sample 
enrichment, and analysis by LC-MS/MS. 
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An early example of the use of chemical modification for enhancement of detectability in the amino acid 
and protein chemistry analysis was the 1963 publication where investigators derivatized amino acids, 
which allowed for their determination by GC/MS [5]. Through chemical modification, sufficient volatility 
and thermal stability was imparted to the analyte to allow for determination by GC/MS, which provided 
for high sensitivity detection. In a similar fashion, our labs strategy to enhance the detectability of P3NY 
began by creating a fluorescent reporter molecule using derivatization. We have shown that we can 
increase the detectability of P3NY by first reducing the nitro group on tyrosine to a reactive amine, and 
subsequently reacting the new species with either benzylamine (BA) or meso-1, 2-
diphenylethylenediamine (DPE) to form a 6-substitued 2-phenylbenzoxazole[6]. This chemical 
transformation results in imparting desirable physical properties, namely fluorescence, which improves 
detectability along with the inherently low detection limits of fluorescence (sub nano-molar in this 
specific case). Additionally, reaction specificity that only targets ortho aminophenols imparts a high 
degree of selectivity with regards to proteomic analysis. 
4.1.2 Specific goals of recently synthesized reagents 
An original objective of the new class of derivatization reagents was improvement of existing 
fluorescent profiles through modification of the molecule so that the emmission wavelength were 
longer. BA and DPE derivatization products have been previously shown to display excitation/emission 
profiles of 360/460 respectively[6]. While such fluorescent properties exhibit a relatively large stokes 
shift of 100 nm putting this particular profile outside of amino acid fluorescence, there is still enough 
auto-fluorescence within a biological sample to exhibit a need for longer excitation/emission 
wavelengths. The modified benzylamine, 4-aminomethylbenzenesulfonic acid (ABS), had been shown to 
increase the emission wavelength from 460 nm to 490 nm[7]. Encouraged by wavelength changes 
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through functional group manipulation, we sought to utilize the dimethylamino-substituent as an 
alternative functional group, which had potential to affect fluorescence in a positive way. 
Despite the positive gains in fluorescence attributed to use of ABS, it has been shown during ABS 
reaction characterization that side product formation can be a concern from BA based derivatization 
reagents[7a, 8]. As shown in Figure 4-4, two known side products are formed from this derivatization 
reaction. While it may be impossible to avoid the formation of the minor intra-molecular side product, 
the issue of the major side product can potentially be addressed.  The expected product from DPE based 
reactions is the same as the major side product from the BA reactions. Moving from BA based reagents 
to DPE based reagents shifts the product distribution to the major side product from the BA reaction 
and eliminates the expected BA product. This shift is expected to lead to an inherent increase in reaction 
yield. 
In addition to improving P3NY detection through fluorescence, we also hope to accomplish 
increased detectability by mass spectrometry. Adding basic functionality to peptides through 
derivatization has the potential to enhance ionization during positive mode mass spectrometry by 
adding additional sites that can carry charge. While many derivatization strategies seek to improve 
ionization through addition of a quaternary amine[9], incorporation of secondary or tertiary amines has 
been used effectively to increase ionization efficiency in peptides by providing addition basic sites for 
protonation[10]. Following from these established gains in ionization efficiency, we have incorporated a 
tertiary amine onto our derivatization reagents with the expectation of increased ionization efficiency 
during positive mode analysis. 
Finally, we hope to incorporate chemical handle for extraction and enrichment of P3NY as a 
means of increasing detectability. To do so, we looked at ion exchange chromatography as a means of 
extraction.  Extraction of peptides through ion exchange has been previously accomplished by attaching 
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a quaternary amine through derivatization. The quaternary amine with peptide attached could then be 
captured by strong cation exchange chromatography[9]. As we already had access to a reagent 
containing a sulfonic acid, we pursued analyte purification through weak anion exchange solid phase 
extraction.  
The overall goal of the present work was utilization of newly synthesized derivatization reagents 
that have potential to further enhance detectability of P3NY. Presented here is the work showing the 
feasibility of the six different reagents produced (previously described in Chapter 3) for derivatization of 
P3NY and subsequent evaluation to determine which reagent would be the best candidate for further 
pursuit. The base reagents used for comparison are BA and DPE. Both have been modified by 
incorporation of a dimethyl amine producing two additional reagents, 4-dimethylaminobenzylamine 
(DMA-BA) and meso-1,2-bis(4-(dimethylamino)phenyl)ethylenediamine (DMA-DPE). The final two 
reagents are sulfonic acid modified BA and DPE, ABS and 3,3'-((1R,2R)-1,2-diaminoethane-1,2-
diyl)dibenzenesulfonic acid (DPE-SA). Within this work, we show relative fluorescent yields among the 
six different reaction products. We also compare relative detectability of the six reaction products by 
mass spectrometry. Results from mass spectrometry also show how product distributions can 
complicate chromatography from BA based reactions. Finally we show how sulfonic acid modified 
reagents can be used for ion exchange extraction and enrichment of P3NY. 
4.2 Experimental 
4.2.1 Reagents and Materials 
 N-cyclohexyl-3-aminopropanesulfonic acid (CAPS), potassium ferricyanate, benzylamine, meso-
1,2-diphenylethylenediamine, and ammonium hydroxide were purchased and used as received from 
Sigma Aldrich (St. Louis, MO). Methanol, OPTIMA grade acetonitrile with 0.1% formic acid, OPTIMA 
grade water with 0.1% formic acid were purchased and used as received from Fisher Scientific 
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(Waltham, MA). Nitrated peptide FSAY(NO2)LER was purchased at 96% purity from BioMatik and stored 
at -20° C until use. Purified water was obtained from a Labconco Water ProPS Filtration Apparatus 
(Labconco Corporation, Kansas City, MO, USA). 
4.2.2 Buffers and solutions  
 A 0.3 M pH 10 CAPS buffer was used for all derivatization reactions. K3Fe(CN)6 was diluted to 10 
mM in CAPS buffer. Stock derivatization solutions were prepared as follows: 0.3 M BA in water, 0.3 M 
DPE in methanol, 0.1 M p-dimethylaminobenzylamine in 1:1 0.1 M pH 3 acetic acid:methanol, 0.3 M ABS 
in 1:1 pH 10 CAPS:methanol, 0.1 M DMA-DPE in methanol, 0.1 M DPE-SA in CAPS buffer. 0.1 M pH 3 
acetic acid buffer solution and 5% ammonium hydroxide in methanol was used for sulfonic acid 
extractions.  
4.2.3 UPLC-MS/MS 
 Relative mass spectrometry measurements and derivatization extraction data were recorded on 
a Waters Synapt G2 quadrupole-tof hybrid mass spectrometer equipped with a nano-electrospray 
source. Separations carried out pre-ionization utilized a Waters nano-ACQUITY UPLC. The UPLC was set 
to a single pump-trapping configuration. The trap column used was an ACQUITY UPLC PST C18 
nanoACQUITY Trap column measuring 180 µm x 20 mm packed with 5 µm particles. The analytical 
column was an ACQUITY UPLC HSS T3 nanoACQUITY Column measuring 75 µm x 150 mm packed with 
1.8 µm particles. Fisher Scientific OPTIMA grade water with 0.1% formic acid was used for mobile phase 
A. Fisher Scientific OPTIMA grade acetonitrile with 0.1% formic acid was used for mobile phase B. 
Following a 1 µL injection, samples were loaded onto the trap column for four minutes with a flow rate 
of seven µL/min with a 97:3 A:B mobile phase composition. Following trapping operation, a linear 
gradient program of 3% B to 40% B over 60 minutes was used. A column wash cycle of 85% B for 5 
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minutes was used after each injection and the column was allowed to re-equilibrate for 10 minutes at 
3% B between each injection cycle. 
4.2.4 HPLC-FL  Detection 
Relative fluorescent comparisons of peptide derivatization products were performed on a 
Shimadzu LC-10 series HPLC consisting of an SLC-10A vp system controller, two LC-10AD vp pumps, and 
SIL-10AD vp  auto-injector and a RXL-10A xl fluorescence detector. Separations were carried out on a 
Vydac Protein & Peptide C18 column measuring 150 x 2.1 mm packed with 5 µm particles. Mobile phase 
A contained 0.1% formic acid in water and mobile phase B contained 0.1% formic acid in acetonitrile. 
Peptides were eluted using a linear gradient program. The program begins at 0% B which is held for 2 
minutes followed by a linear increase in B to 60%. The B concentration is then ramped to 100% for the 
remainder of the run. The column is equilibrated for eight minutes between injections. The fluorescence 
detector was set to record excitation/emission spectra at 360/475. 
4.2.5 Protein Bound 3-nitrotyrosine Derivatization 
FSAY(NO2)LER Reduction. FSAY(NO2)LER was dissolved in a 0.1% formic acid solution and diluted 
to 10 µM. The solution was diluted 1:10 into a 10 mM sodium dithionite solution for reduction of the 
nitro group. During reduction, an Oasis HLB solid phase extraction cartridge was prepared by rinsing 
with 2 mL methanol followed by 2 mL of 0.1% formic acid. After 5 minutes at room temperature, the 
peptide solution was loaded onto the Oasis SPE cartridge. The cartridge was washed by 1 mL of water 
and the peptide was eluted with two 1 mL volumes of methanol. The solvent was evaporated and the 
captured peptide was reconstituted in a buffer appropriate to derivatization at the same approximate 
concentration. An aliquot of sample was (20 µL) was injected onto an HPLC column pre and post-
extraction to determine relative extraction recovery. 
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General derivatization scheme. FSAY(NH2)LER was dissolved into a 0.3 M pH 10 CAPS buffer and diluted 
to approximately 10 µM. 70 µL of pH 10 CAPS buffer, 10 µL of 10 mM K3Fe(CN)6, 10 µl of peptide 
solution, and 10 µL of 0.1 M derivatization reagent were added successively to a 1 mL autosample vial. 
The vial was then vortexed and allowed to incubate at room temperature for 2 hours. Vials were then 
stored at -10° C until analyzed.  
4.2.6 ABS extraction  
 Reduced FSAY(NH2)LER peptide was spiked into a BSA digest resulting in 1 pmol/µL peptide and 
100 fmol/µL digest in a total volume of 100 µL. The solution was derivatized with ABS following the 
derivatization scheme described above. A 10 µL aliquot of derivatized peptide solution was taken and 
analyzed by UPLC-MSMS. Meanwhile, a Phenomenex Strata X-AW 33 u Polymeric Weak Anion Exchange 
cartridge was prepared by flushing with 2 mL of methanol followed by 2 mL of pH 3 acetic acid. The 
remaining derivatization solution was diluted into 10 mL of pH 3 acetic acid and subsequently loaded 
onto the SPE cartridge. The cartridge was then washed with 2 mL of pH 3 acetic acid and then 2 mL of 
methanol. Captured peptide was eluted with a 5% ammonium hydroxide solution in methanol. The 
solvent was evaporated on a water bath under a nitrogen air stream. The solid was reconstituted in 
either 100 µL or 1 mL of CAPS buffer and subjected to UPLC-MSMS analysis. 
4.3 Results and Discussion 
4.3.1 Relative Yields by HPLC-FL 
 Nitrated FSAY(NO2)LER was reduced (Figure 4-1), derivatized by six different derivatization 
reagents (Figures 2 and 3), and analyzed by HPLC to determine relative detectability by fluorescence. 
The fluorescence detector was set to 360/475 ex/em based on upon previously recorded spectra as all 
derivatization products show excitation near 360. While 475 is not an emission maximum for any 
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product, it is an average emission where all products exhibit overlap for detection as BA/DPE products 
show maxima at 460 and sulfonic acid analogs show maxima at 490. 
 The first derivatization reagents (BA and DPE) to be compared provide the foundation for all 
analogs. What is seen in the BA chromatogram (Figure 4-6), which follows from previously published 
work with ABS[7a], is formation of the DPE product (Figure 4-3). Even though 22% of the BA reaction 
product is lost to this side product, the comparable DPE reaction only produces a 69% yield relative to 
the expected benzylamine product (Table 1). From this initial observation, BA could be considered a 
superior derivatization reagent of the two base reagents despite its potential to generate side products. 
 When examining the remaining LC-FL chromatograms, it becomes immediately obvious that 
dimethylamino-substituted products exhibit significantly lower fluorescence intensity when compared 
to other products (Figures 6 and 7). In initial scouting work using 2-amino-p-cresol as a model for P3NY, 
the DMA-BA derivatization reagent failed to produce a fluorescence product despite its formation as 
seen by mass spectrometry. In contrast to those initial results, the DMA-DPE analogue shows 
fluorescent character with excitation/emission profiles similar to that of DPE and BA (Figure 4-5).  The 
utilization of these two reagents in peptide analysis follows this trend.  
DMA-BA and DMA-DPE chromatograms resulting from derivatization at 1 µM peptide 
concentration show too little fluorescence to make a relevant comparison of the two different tertiary 
amine reagents. In order to have a more critical evaluation of the different tertiary amine analogs, 
peptide concentrations were increased 10-fold and derivatized according to the same procedures 
(Figure 4-8). Examining chromatograms from the DMA-BA reaction with increased concentration, we see 
no corresponding increase in observed fluorescence. This leads to the conclusion that observed peaks 
are not derivatization product peaks. This is contrary to the more concentrated DMA-DPE reaction in 
which an increase in analyte concentration is directly proportional to an increase in fluorescence 
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intensity as expected. These results show DMA-BA is a reagent not worth pursuing as it does not 
produce an expected fluorescent product. As DMA-DPE does produce expected fluorescence, it is the 
reagent worth pursuing of the tertiary amine derivatization analogs. 
The remaining derivatization reagents for comparison are the sulfonic acid analogs of BA and 
DPE: ABS and DPE-SA. Both exhibit much lower fluorescence intensity than either BA or DPE. In the 
chromatogram for ABS derivatization, one observes the previously reported side products (Figure 4-6). 
The DPE-SA product is seen in the ABS chromatogram constituting 23% of the total product yield. At the 
wavelengths used for detection, the ABS total relative yield is only 40% of the BA product (Table 1). 
Upon examination of the DPE-SA chromatogram, two peaks are seen (Figure 4-7). The 
chromatogram produced by UPLC-MS also shows two closely eluting peaks (Figure 4-11). It is possible 
that despite extensive work in DPE-SA purification that the purified derivatization reagent still exists as a 
mixture of isomers. With such a product distribution taken into account, DPE-SA still produces only 7% 
relative fluorescence intensity compared to BA and only 17% relative fluorescence intensity when 
compared to ABS. Due to the extensive difficulties from purification of DPE-SA and the less relative 
fluorescence intensity, ABS would be preferred reagent of the two sulfonic acid analogs. 
4.3.2 Relative Detectability by UPLC-MS/MS 
Over the course of this investigation, the proteomics field has evolved from its infancy to a more 
mature discipline. Mass spectrometers have progressed as the de facto detectors within this field when 
paired with soft ionization techniques such as ESI or MALDI, which as soft-ionization techniques result in 
minimal peptide fragmentation[11]. In 2010 the University of Kansas acquired a Syanpt G2 to further 
current research within proteomics. With the necessary technology in place, making enhancements to 
detectability via derivatization during mass spec analysis has become a primary goal in recent years. 
Adding basic functionality to peptides through derivatization has the potential to enhance ionization 
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during positive mode mass spectrometry by adding additional sites that can carry charge. While many 
derivatization strategies seek to improve ionization through addition of a quaternary amine[9], 
incorporation of secondary or tertiary amines has been used effectively to increase ionization efficiency 
in peptides by provide addition basic sites for protonation[10]. Following from these established gains in 
ionization efficiency, we have incorporated a tertiary amine onto our derivatization reagents with the 
expectation of increased ionization efficiency during positive mode analysis. 
When evaluating relative yields by mass spectrometry, it must be mentioned that yields 
produced from such analysis are in no way quantitative. Further, several factors play into what 
determines analyte detectability by mass spectrometry. Mode of acquisition is important within the 
setting of these comparisons. Although positive mode ionization is generally seen as capable of 
producing better spectra, it may not be the case for analysis of sulfonic acids. Ionization efficiency must 
also be considered as a goal of conducting analyte derivatization. Within this context, it should be noted 
that ionization is a variable which changes during the course of a chromatogram causing as much as a 
15% change in relative detectability. The typical means of mitigating such variability is through use of 
internal standards[12]. This was not done here as it falls beyond the scope of the current project. Finally, 
while peptide samples could be generated and analyzed repeatedly by HPLC-FL, instrument availability 
and time restraints for the UPLC-MS limited data collection to single runs per derivatization reagent. 
With current limitations on how mass spectrometry data should be considered, some general 
conclusions and observations could be made about the relative detectability of the six-derivatization 
products. Upon initial comparison of BA product to DPE product, a 40% gain in ion counts is seen from 
the DPE product (Table 2). A possible reason for gains in DPE product detectability by mass spectrometry 
could be from the nature of sample ionization. The BA product requires a higher percentage of the 
organic modifier for elution. Higher organic composition is generally seen to enhance ionization 
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efficiency. Because of this, the reason for gains in DPE ionization must stem from structural attributes. 
When comparing the DPE product structure to the BA product structure, the difference lies at the 6- 
position of the benzoxazole ring. The BA product carries a benzylamine at said position where the DPE 
product has a primary amine at the same position. It is possible the primary amine is easier to charge 
during ESI than the secondary amine from the BA product. 
A second surprise resulting from data generated during mass spectrometry analysis is the 
relatively high abundance of the ABS product when compared to the BA product. One might expect an 
analyte containing multiple sulfonic acids to be inhibited during positive mode ionization. However, as 
mobile phase pH has been shown not to affect positive mode ESI[13], such worries can be dismissed. 
Several possibilities exist for why an enhanced response is attained from ABS derivatization compared to 
BA derivatization. A direct increase in observable ions could arise if the ABS product has a higher 
potential to ionize more efficiently than the BA product. A second possibility for the enhanced ionization 
could be from less product loss due to side product generation. BA derivatization chromatograms reveal 
a higher percent of side product ions when compared to ABS derivatization from both fluorescent and 
mass spectrometry data. While mass spectra results are not quantitative, it could point to loss of relative 
yields because of side product formation.  
4.3.3 Side Product Formation and Considerations 
 It has been previously reported through use of APPD and ABS that side product formation is a 
concern when BA is used as a derivatization reagent. A general observation from use of these reactions 
can be made when considering the reaction mechanism. For the reaction to proceed, a 2-aminophenol 
is placed in an oxidative environment to generate an ortho-quinone imine. This highly reactive 
intermediate is subject to nucleophile attack by any available nucleophile. In order to mitigate product 
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loss through side product formation, an unusually large excess of derivatization reagent is used. 
However, this approach at preventing side product formation is not completely successful. 
In the case of the peptide FSAYLER, in addition to the expected 2-phenyl-6-
benzylaminobenzoxazole, the N-terminal primary amine participates in an intra-molecular attack at 
position 6, which results in a cyclic side-product (Figure 4-4). Formation of this product cannot be 
prevented without previously blocking reactive amines. Within the current studies, the BA derivatization 
reaction produced 4.3% of the intra-molecular product, while the ABS reaction produced a negligible 
0.3% relative ions of the analogous product as determined by mass spectrometry. As a goal of this 
research is to prevent the need for prior reactive site blocking, the observed 5% product loss is deemed 
acceptable.  
Of higher concern when taking a critical look at peptide derivatization (FSAYLER) data, the 
product resulting from DPE based reactions is seen to form within BA reactions (Figures 2-4). The reason 
for the observed DPE product has been speculated to be from reaction with ammonia. While there is no 
ammonia initially present in the sample, it can be generated from BA oxidative degradation. A general 
trend for formation of the DPE product within BA based reactions is for 15% of product formation to 
proceed down this side path. When examining LC-FL chromatograms for both BA and ABS derivatization 
reactions, DPE side product formation is found to be consistent with the BA reaction producing 22% side 
product and the ABS reaction producing 23% side product (Table 1). While mass spectra for both of 
these reactions support correct product identification, the relative ion counts are much more 
conservative at 3% for BA and 5% for ABS (Table 2). 
Examination of LC-FL chromatograms and mass spectra for DMA-BA derivatization reactions 
reveals no formation of the expected reaction product. Upon further examination of LC-MS 
chromatograms, masses corresponding to the expected potential side products are observed (Figure 4-
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10). Both the DMA-DPE based reaction product and the intra-molecular product are observed to form 
within the DMA-BA derivatization. Unique to this reaction, the intra-molecular product is observed in 
higher ion counts than the DPE based product.  
Unlike the BA based reactions, DPE based reactions have not been shown to produce side 
products. Examination of chromatograms produced by mass spectrometry reveals that an intra-
molecular product can result from DPE based reactions. However, as the relative ion counts all fall 
below 0.1% of the expected products, such side product formations can be largely ignored. 
4.3.4 ABS purification 
As P3NY is an extremely low abundant post-translational modification, increasing detectability 
through extraction has become a prominent goal. Analyte extraction remains a sure way for sample 
purification and sample enrichment, both of which can lead to increased selectivity and increased 
sensitivity[14]. Several different extraction handles have been attempted for P3NY through derivatization 
reagents. Most recently APPD, a derivatization reagent that contains a cis-diol functional group, has 
been shown to be a capable derivatization reagent for P3NY. The cis-diol of APPD acts as a handle for 
extraction when paired with boronate-affinity chromatography[8]. Following the success of APPD, we 
sought to achieve a reagent capable of extraction with an additional goal of the reagent being easier to 
acquire. 
 At the time of this writing, ABS has become an established derivatization reagent for enhancing 
detectability of P3NY. ABS contains several features which make it attractive as a derivatization 
reagent[7a]. It is easy to acquire through a simple sulfonation reaction. Through control in reagent 
formation, stable heavy isotopes can be incorporated for relative quantitation. The products resulting 
from ABS derivatization exhibit fluorescence with ex/em of 460/490 nm. An aspect that not previously 
pursued was the evaluation of ABS derivatives as the basis of a sample preparation strategy utilizing the 
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sulfonic acid moiety of the product.  The pKa of benzensulfonic acid is 0.7, which is substantially lower 
than the pKa of any expected carboxylic acids present on peptide analytes (expected pKa 4-5). This 
provides an opportunity for selective ionization of the sulfonic acid while maintaining peptide associated 
carboxylic acids as the neutral species through pH control.   
Recognizing the potential for attaining selective functional group ionization (sulfonic acid versus 
carboxylic acid) via pH control, which will only occur for peptides that have undergone derivatization 
with ABS, one can envision the development of a selective solid-phase extraction procedure wherein the 
reduction of sample complexity while accomplishing sample enrichment is possible, if an appropriate 
extraction phase can be identified.  To this end, anion exchange is an obvious choice for ABS derivative 
extraction. When choosing between strong anion exchange and weak anion exchange, we considered 
what different functional groups each different stationary phase contained. Strong anion exchange 
typically incorporates a quaternary amine. We were concerned that using a stationary phase of fixed 
positive charge would result in the product being irreversibly bound to the extraction phase. With this in 
mind, we found a weak anion exchange solid phase extraction cartridge, which contained a diamine 
bound to a polymeric support. In addition to the expected electrostatic interaction, the presence of an 
aromatic ring system provides the stationary phase with hydrophobic interactions and potential pi-pi 
stacking, which would provide for two separate retention mechanisms for the ABS derivatives.  
To test the effectiveness of the strata x-aw cartridges, FSAY(NH2)LER was spiked into a bsa 
digest standard at an equimolar concentration (100 fmol/µL for each). The peptide mixture was then 
subjected to the established derivatization procedure. After completion of the derivatization reaction, 
the solution was adjusted to pH 3 and loaded onto the SPE cartridge (Figure 4-13). At this pH, the 
product is expected to be retained, with all other peptides flowing through the device to waste.  As the 
primary retention process is through electrostatic interaction, this particular extraction allows for 
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washing by pure organic which is favorable to washing away all unwanted peptides. The extracted 
analyte is then subsequently released by washing with an ammonium hydroxide solution in methanol. 
The pH shift results in the de-protonation of the support, with the captured derivative being released 
and isolated as a substantially purified solution (Figure 4-14). The isolated extract can then be 
evaporated and reconstituted for an enhancement of analyte sensitivity (Figure 4-15).  
 4.4 Conclusions 
 Six different derivatization reagents were utilized in order to enhance the detectability of P3NY. 
BA has been previously reported as a reagent capable of chemically modifying ortho-aminophenol’s 
under oxidative conditions in order to create a fluorescent reporter molecule. The inherently low 
detection limits of fluorescence detection makes BA a valuable and economical reagent for enhancing 
detection of P3NY. DPE is a structurally similar reagent that produces a slightly different reaction 
product when used for derivatization. Despite BA’s potential for side product formation, it has been 
shown within this work to produce higher relative product yields by both fluorescence and mass 
spectrometry measurements.  
 The dimethylamino analogs of both BA and DPE were pursued as derivatization reagents. It was 
hypothesized that incorporation of a tertiary amine could positively affect fluorescence spectra and lead 
to increased ionization during mass spectrometry analysis. DMA-BA as a derivatization reagent was 
shown to be ineffective as the predicted reaction product failed to form. Despite this, side products 
related to other BA reactions were generated from this analogue; however, DMA-DPE did form the 
expected derivatization product. Relative fluorescence yields and relative ion counts from mass 
spectrometry were both lower than those produced by BA, thus negating the usefulness of this DPE 
analog. 
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 ABS proved to be a very useful modification of BA, with properties that possessed advantageous 
physical-chemical properties. Despite moderately lower relative fluorescent yields, ion counts by mass 
spectrometry were shown to be higher. In addition, side product formation from ABS compared to BA 
was shown to be lower. Additionally, ABS was shown to provide further utility through use in weak 
anion exchange solid phase extraction. DPE-SA as a derivatization reagent proved to be disappointing 
providing lower product yields compared to other reagents. Despite extensive reagent purification, 
evidence of reagent isomers can be seen through split product peaks. With the difficulties involved in 
obtaining pure reagent, DPE-SA does not appear to be a derivatization reagent of value. With the ease 
of acquisition, relatively high product yields, and its ability to be used in solid-phase extraction, ABS was 
shown to be the reagent of highest utility amongst the six reagents tested within this work.  
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4.5 Chapter 4 Figures 
 
 
Figure 4-1. Sodium dithionite reduction of protein bound 3-nitrotyrosine to 3-aminotyrosine 
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Figure 4-2. Derivatization reactions of the three BA based reagents. (Top) Benzylamine (BA) derivatization. (Middle) 4-
Dimethylaminobenzlamine (DMA-BA) derivatization. (Bottom) 4-aminomethylbenzenesulfonic acid (ABS) derivatization. 
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Figure 4-3. Derivatization reactions of the three DPE based derivatization reagents. (Top) Diphenylethylenediamine (DPE) 
derivatization. (Middle) 1,2-bis(4-(dimethylamino)phenyl)ethylenediamine (DMA-DPE) derivatization. (Bottom) 3,3'-(1,2-
diaminoethane-1,2-diyl)dibenzenesulfonic acid (DPE-SA) derivatization. 
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Figure 4-4. ABS derivatization showing potential product distribution with 75% expected benzoxazole product, 7% 
intramolecular product, and 18% DPE-SA product. 
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Figure 4-5. LC-MS-FL chromatograms showing DPE derivatization of 2-aminocresol producing product peak mass which 
matches fluorescence. 
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Figure 4-6. HPLC-FL chromatograms from three different BA based derivatization reactions. (Top)BA derivatization of 
FSAY(NH2)LER with BA product at 13.5 min and DPE product at 11 min. (Middle) DMA-BA derivatization of FSAY(NH2)LER 
showing no product. (Bottom) ABS derivatization of FSAY(NH2)LER showing ABS product at 8.5 min and side product at 9.5 
min. 
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Figure 4-7. HPLC-FL chromatograms from three different DPE based derivatization reactions. (Top) DPE derivatization of 
FSAY(NH2)LER with expected product at 11 min. (Middle) DMA-DPE derivatization of FSAY(NH2)LER showing expected 
product at 11.7 min. (Bottom) DPE-SA derivatization of FSAY(NH2)LER showing split product peak at 8.6 and 8.9 min. 
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Figure 4-8. HPLC-FL chromatograms of (Top) DMA-DPE derivatization reaction with increased FSAY(NH2)LER concentration 
showing increase in reaction product at 11.7 minutes and (Bottom) DMA-BA reaction with increased FSAY(NH2)LER 
concentration showing no product formation. 
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Reagent 
Retention Time 
(min) Peak Area Average Area Relative Yield 
BA 13.5 2987776 2962565 100.0000 
  
2959201 
  
  
2940719 
  BA (DPE Product) 11 814382 843005 28.4552 
  
863546 
  
  
851087 
  ABS 8.5 1064783 973501 32.8601 
  
956125 
  
  
899596 
  ABS (DPE Product) 9.5 222346 225237 7.6028 
  
230600 
  
  
222766 
  DMA-BA NA NA NA NA 
DPE 11 1911932 2037267 68.7670 
  
1915638 
  
  
2284230 
  DMA-DPE 11.7 415441 394584 13.3190 
  
377857 
  
  
390453 
  DPE-SA 8.6 93736 99336 3.3530 
  
113496 
  
  
90776 
  DPE-SA 8.9 94261 108558 3.6643 
  
128032 
  
  
103380 
       
Table 4-1. HPLC-FL results from derivatization of FSAY(NH2)LER by six different derivatization reagents. Relative yields are 
normalized to BA derivatization product peak area. 
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Figure 4-9. Derivatization product spectra from derivatization of FSAY(NH2)LER by (1) BA, (2) DPE, (3) ABS, (4) DMA-DPE, and 
(5) DPE-SA 
5 
2 1 
3 4 
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Figure 4-10. UPLC-MS chromatograms from derivatization of FSAY(NH2)LER by (Top) BA, (Middle) DMA-BA, and (Bottom) 
ABS. 
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Figure 4-11. UPLC-MS chromatograms from derivatization of FSAY(NH2)LER by (Top) DPE, (Middle) DMA-DPE, and (Bottom) 
DPE-SA. 
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Reagent 
Elution Time 
(min) 
Ion Counts (max 
height) Peak Area 
Relative BA 
Yield 
BA 50.1 4.55E+04 1.04E+08 100.0000 
BA (DPE product) 36.5 1.32E+05 2.88E+06 2.7692 
BA (Intramolecular product) 35.4 2.35E+05 4.85E+06 4.6635 
DMA-BA NA NA NA NA 
DMA-BA (DPE product) 39.0 1.93E+05 2.04E+06 1.9615 
DMA-BA (Intramolecular 
product) 38.2 3.65E+05 8.55E+06 8.2212 
ABS 35.5 4.39E+05 1.27E+08 122.1154 
ABS (DPE product) 27.5 5.49E+05 5.49E+06 5.2788 
ABS (Intramolecular product) 31 4.49E+04 3.98E+05 0.3827 
DPE 34.5 1.48E+06 1.45E+08 139.4231 
DMA-DPE 38.6 3.85E+05 1.39E+07 13.3654 
DPE-SA 31.1 7.59E+05 1.92E+07 18.4615 
DPE-SA 31.6 5.09E+05 1.29E+07 12.4038 
 
Table 4-2. UPLC-MS data of FSAY(NH2)LER derivatization showing relative ion counts for six different 
derivatizations along with products found within each reaction. Yields are normalized to BA derivatization 
product. 
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Figure 4-12. UPLC-MS chromatogram of bovine serum albumin digest. FSAY(NH2)LER was spiked into the digest and the 
peptide solution underwent derivatization by ABS. ABS product peak shows at 34.8 minutes with product mass of 626.22. 
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Figure 4-13. ABS product extraction from a BSA digest derivatization solution. Reaction product extracted on a phenomenex 
strata x-aw SPE cartridge for isolation and enrichment. 
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Figure 4-14. UPLC-MS chromatogram of ABS reaction product post extraction and subsequent dilution to pre-extraction 
concentration. 
  
133 
 
 
Figure 4-15. UPLC-MS chromatogram of ABS derivatization product after SPE and subsequent enrichment by reconstitution in 
ten times less solvent. 
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Appendix 
Implementation of Chromatographic Systems  
Which Surpass Commercial Pressure Limits for  
Enhanced Resolution and Peak Capacity  
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A1.1 Introduction 
A1.1.1 Current challenges in proteomics 
 In the wake of the completion of the human genome project, it has come to light that humans 
make use of approximately 30,000 protein encoding genes[1]. It has since been estimated that these 
genes encode for close to one million different proteins when structural variants and post-translational 
modifications are taken into account [2]. Current techniques for biomarker discovery are arduous feats at 
best that require substantial steps in protein purification. Purified proteins are commonly digested into 
substituent peptides making them more amenable towards analysis. The de facto tool for identification 
post sample clean-up and digestion is LC-MS. Mass spectrometry provides a powerful tool for qualitative 
identification of peptides allowing for computational identification of parent proteins[3]. Recent 
advances in ionization techniques and computational analysis has allowed for label-free quantitation. 
Despite promising advances in mass spectrometry, biomarker discovery is still complex due to the need 
for extensive sample pre-treatment to reduce sample complexity as well as remove substances not of 
interest that have detrimental efforts on the chromatographic and mass spectrometry systems.  
Recent considerations to reduce the complexity of sample clean-up have aimed at improving 
chromatographic performance[4]. Although mass spectrometry does not require baseline resolution for 
identification of peptides, co-elution can result in ion suppression and added complication during 
construction of tandem mass spectrometry data sets that are essential for protein identification[5]. The 
requirement for sample clean-up stems from the inability of current chromatographic methods to 
efficiently separate more than several dozens of peptides. As a cellular compartment can contain 
thousands of different proteins made of tens to hundreds of peptides, the current sample preparation 
strategies are extensive in order to provide pure protein digests which current chromatography columns 
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are able to efficiently separate. Increases in column performance could lead to direct gains in sensitivity 
by excluding the need for preparatory steps which could result in loss of protein.   
A1.1.2 Theoretical Basis for Long Axial Columns 
Column separation efficiency is quantitatively described by the number of theoretical plates, N, 
represented in equation 1 where L represents column length and H represents the height equivalent of 
 
 
   
 
 
 
(1) 
 
a theoretical plate. From equation 1 it is seen that separation efficiency is directly proportional to 
column length, which will be the focus of the proceeding work. However, several other factors directly 
affect separation efficiency that should not be ignored.  
H can be generally described by the van Deemter equation (2) where u represents linear 
velocity, the A term represent eddy diffusion, the B term represents longitudinal diffusion, and the C 
term represents resistance to mass transfer. Each term can be examined in greater 
 
     
 
 
   
(2) 
detail by the expanded van Deemter equation 3 where   represents particle shape, dp represents 
particle diameter, Dm is the diffusion coefficient of the analyte in the mobile phase, u is the linear 
velocity, and   and  are constants. Several conclusions can be drawn from the expanded van Deemter. 
 
       
    
 
 
   
  
  
 
(3) 
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First we see that eddy diffusion is determined by particle size and shape. Irregular particle shape can 
create different sized channels through which analytes diffuse. Diffusion of analyte through several 
different sized channels results in peak broadening.  Following from this, more uniform particle shape 
along with smaller particle size can lead to more uniform inter-particle channels, thus minimizing the A 
term. From the B term we see that longitudinal diffusion is determined by analyte diffusion coefficients 
and linear velocity. As such, it is usually seen as constant for a given analyte on a given column and can 
only be adjusted through changes in linear velocity. Finally, the C term shows that mass transfer is 
affected by analyte diffusion coefficients, linear velocity, and most importantly particle size. The 
importance of the C term which one can intuit that smaller the particle size, the more efficient the mass 
transfer of an analyte from stationary phase to mobile phase, which ultimately results in a more efficient 
separation.  
Overall, examination of the van Deemter equation allows one to quantitatively explain how 
separation efficiency can be increased through use of small particles and optimal linear velocities. The 
van Deemter minimum for most columns utilizes a linear velocity of 0.1 cm/s. Despite this, linear 
velocities of 0.2 cm/s are much more common to mitigate the amount of time needed to operate at van 
Deemter minimums. The loss in efficiency due to increasing linear velocity can be mitigated through use 
of smaller particles.  
A1.1.3 Pressure Limitations  
 As discussed, chromatographic separation efficiency can be increased through decreasing 
particle size and increasing column length. The consequence of both of those changes is an increase in 
back pressure. For comparison, conventional HPLC utilizes columns between two and 25 cms in length 
containing a 4.6 mm inner diameter (ID) with particles ranging from 3-5 microns. Expected back 
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pressure for conventional HPLC is from 1,000 to 4,000 psi. More recently, UPLC utilizes 1-3 micron 
particles in columns 10 to 25 cm in length with an internal diameter of 2.1 mm. Expected back pressure 
for UPLC is from 4,000 to 10,000 psi. Currently, there is not a commercially available instrument 
designed for pressures above 15,000 psi. As discussed by Jorgenson[6], if pressure was not a limiting 
factor, particle size and column length can be optimized for a given pressure. At 45,000 psi, optimal 
particle size is one µm and optimal column length is 30 cm[6]. With those parameters in mind, his lab 
constructed apparatus capable of packing sub-two micron particles into fused silica capillary columns up 
to two meters long. Additionally, his lab modified a Waters nanoACQUITY[7] in order to utilize the 
custom-made columns. Reported in the following work is the attempt to replicate production of long 
axial columns utilizing sub two micron particles at KU. 
A1.2 Long Axial Column Packing and Preparation 
 The goal of the present work is to produce increases in peak capacity through longer columns. 
The following sections describe the process of packing sub-2 µm particles into fused-silica capillary to 
create columns of higher plate counts than those commercially available. Fused silica capillary (75µm ID) 
was selected for use in packing. BEH ACQUITY particles (dp = 1.7 µm) were used for all packing 
operations, which allow for direct comparisons to commercially available columns 
A1.2.1 Procedures for Fritting 
 It should first be noted for all fritting procedures that cleanliness is of extreme importance, as 
dust particles can have unwanted consequences for packing procedures. Lab space used for fritting 
should be thoroughly cleaned prior to set up and fritting. Appropriate protection equipment should be 
worn including a lab coat, safety glasses, and most importantly, nitrile gloves. There are several methods 
to producing column frits which are well covered in literature and fall beyond the scope of the current 
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project. For the purpose of producing meter long columns, two general procedures were used. Both 
procedures used a mixture of kasil and formamide which polymerizes in the end of the capillary tube. 
 For the first procedure, a 3:1 mixture of kasil:formamide was mixed in a 1.5 mL Eppendorf vial. A 
1.3 m piece of 75 µm ID 360 µm OD length of capillary was dipped end-wise (approximately 1 cm deep) 
into the vial. The end was immediately removed and placed in an oven set at 70° C and allowed to cure 
overnight. Prior to packing, the same end was cut leaving a 1-2 mm frit at the outlet end of the capillary 
and the rest of the fritted section was thrown to waste. 
 The second procedure follows more closely to the procedures used at the University of North 
Carolina. A kasil solution (20 µL) was placed and absorbed onto a piece of filter paper (Fisherbrand Glass 
Fiber Filter Circles; G4).  Formamide (20 µL) was placed directly on top of the kasil spot on the filter 
paper. The outlet end of a 1.3 m piece of 75 µm ID x 360 µm OD length of capillary was dabbed onto the 
kasil solution spot. Gentle twisting motions were applied to the capillary and small holes were bored 
through the filter paper. The capillary was then placed in an oven at 70° C for at least two hours prior to 
packing. 
A1.2.2 Packing station 
 For packing columns of up to two meters in length, a packing station was used according to 
Figures 2 and 3. The stations consist of a Haskel DSF-100 and a Haskel RDSXHF-903 air drive liquid 
pumps. The former pump operates well in the one to twenty thousand psi range and the latter in the 
five to 75 thousand psi range. Liquid reservoirs for push solvents are stored in the top rack above the 
pumps. The solvents are connected to the DSF-100 pump which is then connected in series to the 
RDSXHR-903 pump. The outlet of the latter pump is then connected to the custom made packing bomb. 
The packing bomb (Figure A-3) consists of a solvent reservoir capable of holding ~1 mL of fluid with 
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bomb inlet facing the pumps and bomb outlet pointing up.  The bomb contains a micro magnetic stir-bar 
and sits upon a stir plate.  
A1.2.3 High pressure fittings 
 Every fused-silica capillary connection (both for packing procedures and for all connections in 
XUPLC system utilization), which must contain pressures greater than 10,000 psi is made with 
proprietary high-pressure fittings obtained from the University of North Carolina. The fittings, seen in 
Figure A-1, consist of a backing nut, a backing ferrule, a union nut, a peek ferrule, and a capillary sleeve 
(not shown). The peek ferrule is drilled out to 380 µm prior to making a connection. The capillary is 
fitted with the sleeve (1/32” x 0.15”) and all fitting pieces save the drilled ferrule are placed over the 
sleeve in the appropriate order as displayed in Figure A-1. The drilled ferrule is placed directly on the 
polyamide coating at the head of the capillary where the connection is to be made. The union nut is 
screwed down against the peek ferrule at the desired connection point with appropriate force to hold 
pressure, but taking care not to break the union. The backing ferrule is screwed down over the Teflon 
sleeve by the backing nut. The backing ferrule applies appropriate force along the length of the sleeve to 
keep the column from sliding out of the primary ferrule. 
A1.2.4 Column packing 
 It should first be noted that cleanliness is a high priority for all packing procedures as 
contamination of packing equipment, fused-silica capillary, or slurry preparation by dust particles leads 
to packing failure. Appropriate protective lab wear should be adhered to including lab coat, protective 
eye wear, and nitrile gloves. Without proper cleanliness at all stages of packing, there is a high 
probability of packing failure. Prior to packing, a 1.3 m piece of capillary is fritted on one end according 
to previously describe fritting procedures. The fritted end will be the outlet of the column. The packing 
material is prepared as a 50 mg/mL slurry in methanol, vortex mixed for 15 second, then placed into a 
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sonic water bath for 15 minutes. The slurry is then vortex mixed for an additional 15 seconds and 400 µL 
of the suspension is placed into the packing bomb using a one mL Hamilton syringe (Hamilton #81316; 
1001LTN 1.0 mL (22/2"/3)). The non-fitted inlet of the capillary is fitted to a half-inch adapter piece by a 
high pressure fitting with 3.5 cm of the capillary extended beyond the connection end of the adapter. 
The protruding length of the capillary is cleaned by wiping with a methanol wetted Kimwipe. The 
capillary is placed into the packing bomb taking care not to bump the fragile end of the capillary. The 
adapter is tightened to hold pressure up to 45,0000 psi.  
The stir plate is switched on to a speed of six. The DSF-100 pump is turned on and pressurized to 
approximately 1,000 psi using acetone (HPLC grade) as a packing solvent. Appropriate care should be 
considered at this point to avoid failure of the kasil frit as failure will result in spraying silica particles 
over the work area. In such an event, the system needs to be immediately shut off and packing material 
cleaned from the work area. If the frit holds, the column outlet needs to be monitored for bed 
formation. After one to two cm of bed has formed, the RDSXHF-903 can be activated and slowly 
pressurized. Care should be taken as the second pump does not pressurize until approximately 5-10k 
psi. Pressure on the high pressure pump should be increased to 40k psi at a rate of 5k psi per cm of bed 
formed. Frit failure is of high concern until the system is fully pressurized. Attention should also be given 
to the high-pressure capillary connection at the bomb exit to monitor for a leak. 
After the system has come to pressure with no leaks detected, the column should be allowed to 
pack fully, with monitoring possible using a low-amplification microscope. A one meter column should 
pack in under three hours. If at any point there is an interruption in packing (such as a clog in the 
packing inlet), the pump pressure can be released and immediately reapplied in an attempt to resume 
packing. After the column has packed, air supply to liquid pumps should be turned off to allow the 
column to very slowly depressurize over the course of half an hour and the stir plate should be turned 
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off. The half inch adapter can be unscrewed from the packing bomb, but the column should remain 
fitted to the adapter for washing. 
A1.2.5 Column Washing 
In order to allow the column bed to settle appropriately, columns are washed after packing at 
higher pressures than they are packed. A 1:1 solution of acetonitrile:water (HPLC grade acetonitrile and 
Millipore water) is used as washing solvent and the appropriate reservoir is attached to the washing 
station pump. The packed column with half-inch adapter still attached is attached to the washing 
station. The 3.5 cm piece of column protruding from the adapter is cut and the adapter is attached to 
the high pressure haskel 903 pump. The pump is pressurized to approximately 50k psi and the column is 
allowed to wash for at least ten column volumes. After the appropriate time has passed, the air supply 
to the pumps can be turned off so the column slowly depressurizes. After the column is fully 
depressurized, the pump is turned back on and pressurized up to 10k psi. A temporary frit is then 
fabricated on the inlet side of the column by placement of the capillary between the jaws of a Teledyne 
Stripall device (Model TWC-1) using setting 4-5 for approximately 60 seconds. The column can then be 
detached, taking care not to break the newly formed temporary frit, and is allowed to dry. After drying, 
the temporary frit is cut off and a permanent frit is made at the inlet according to previously described 
kasil fritting procedure. The column inlet is tested for strength by connection to a high pressure pump, 
pressurizing the column to 40k psi, and rapid depressurization. A column is deemed fit for use if the inlet 
frit survives 4-5 rapid decompressions without particles leaking out of the inlet.  
A1.3 Extreme Ultra-High Pressure Liquid Chromatography (XUPLC) 
A1.3.1 UPLC modification 
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 For utilization of long axial columns packed longer than 25 cm’s, the following modifications 
have been made to a Waters nanoACQUITY UPLC (Figure A-4). From the 6-port Rheodyne valve located 
at the top right side of the sample manager, a connection capillary (Waters part number 430002242) 
was fitted leading out from the 6-port valve to a valco T (part MT.5XCS6, 1/32” x 0.006”). From the valco 
T, a 17 cm length of 75 µm ID capillary leads to the 10k psi pin valve labeled Valve 2 and is connected at 
the valve’s front port. The side port on Valve 2 is connected to appropriate tubing (1/16” ID) leading to 
waste.  
From the remaining port on the Valco T, a 23 cm length of 75 µm ID fused-silica capillary leads 
to a 40k psi pin valve labeled Valve 3 and is connected to the side port of the valve. A 52 cm piece of 75 
µm fused silica capillary connected by Waters high pressure fittings leads out of the front port on Valve 
3. The same piece of capillary is connected to the column Valco T, which sets inside the column heater, 
by a high pressure fitting. Of the two remaining ports on the column Valco T, the column inlet is 
attached through a high pressure fitting. The column outlet is attached to a “pig tail”. The pig tail is a 15 
cm piece of 20 µm fused silica capillary that connects the column to the nanoESI source. The column pig 
tail fitting is a 4 mm piece of Teflon tubing (1/16” x 0.008”), which has been drilled out to 360 µm. This 
piece of Teflon tubing is then slid over the column outlet and pig tail, connecting the two. 
The remaining port on the column Valco T which sits in the column heater is connected to a 
1/32” x 0.005” X 40 m long piece of stainless steel tubing which serves as the gradient storage loop. The 
gradient storage loop is connected at the other end to a vent Valco T. Of the two remaining ports on the 
vent Valco T, one is attached to a 10 cm piece of stainless steel tubing (1/32” x 0.005”). The other end of 
the stainless steel tubing is attached at the front port of a 40k psi pin valve. The side port on the 40k psi 
pin valve is attached to appropriate plumbing for waste.  
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The remaining port on the vent Valco T is attached to 140 cm of 20 µm fused silica capillary by a 
high pressure fitting. This same piece of capillary is attached through a high pressure fitting to a 0.5” 
adapter. The adapter is connected to a HiP 3-way valve. One port on the HiP valve is connected 
appropriately to waste with the remaining port connected through stainless steel connections and 
tubing to the Haskell 903. 50:50 Water:Acetonitrile is plumbed appropriately to the Haskell pump and 
used as push solvent. The assembled additions can be seen in Figure A-5. 
A1.3.2 General Operation Notes 
 With regards to operation of the XUPLC, there are two general directions solvent can be pushed. 
For loading-type events, such as gradient loading, sample loading, or storage loop flushing, valve two 
remains closed while valves three and four are open. This allows solvent to fill the gradient storage loop 
and be pushed through the end of the loop to waste. For operation and data collection, valves three and 
four are closed, valve two is opened, and the Haskell pump is turned on. In this state, the current 
contents of the gradient storage loop are forced through the analytical column. Valve two remains open 
during operation to prevent pressure build-up from the nanoACQUITY and also serves to prevent the 
nanoACQUITY from experiencing higher than designed for pressure in the event of valve three failures. 
A1.3.3 New Operation and Leak Checking 
 Whenever a high pressure connection is made, or after a change to XUPLC operation is made, a 
pressure check should always be performed. The main cause of experimental failure for XUPLC 
operation is due to a leak in the system. Most leaks can be found prior to operation which saves hours 
of experimental time.  
 Leak checking should be approached from two directions with valve three as a mid-point. From 
the nanoACQUITY side, a standard pressure check should be performed under the Intellistart diagnostics 
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menu found in the BSM (Binary Solvent Manager) sub-section. Prior to this test, valves two and three 
should be set to the off position. With those valves closed, the leak test should pass at under 30 nL/min 
of solvent loss at 10,000 psi. If more solvent is lost than acceptable, lines of capillary can be frozen to 
determine where the leak is occurring. An easy way to accomplish freezing is by turning a can of 
compressed air upside down and spraying the appropriate length of capillary. Connection points where 
fittings occur tend to be the highest probable sites where leaks are occurring. 
 Leak testing from the Haskell side can be a bit more troublesome as there are more potential 
sites of leakage, which also need to hold higher pressures. With the appropriate valves toggled for the 
system to be in operating mode, the Haskell pump can be turned on and all connection points should be 
inspected for fluid accumulation after 15-20 minutes of the pump being activated. To ensure normal 
operation will proceed as planned, the Haskell pump should be pressured to 40,000 psi for leak 
checking. If a leak event is not discovered after 20 minutes at 40,000 psi, the pump pressure can be 
dialed down to normal operation pressure of 30,000 psi. If fluid is detected, the fitting should be re-
made and rechecked. In addition to waiting for fluid formation, the Haskell pump itself can often times 
give clues to leaking. If the drive shaft is visibly moving when the pump is on, there is a leak present. In 
addition to checking fittings for visible fluid accumulation, the waste ports of pin valves should also be 
examined for leakage. 
A1.3.4 New Column Use 
 The day before a new column is to be used, the column needs to be fitted to the XUPLC for 
rinsing. An experimental file using 95% organic modifier should be used to flush the column overnight 
and can be created by modifying experimental files seen in Figures 8 and 9. The method for doing so is 
as follows. Valve 4 and Valve 3 should be set to on for them to open with Valve 2 set to off to direct 
solvent flow through the gradient storage loop. The inlet method file should be set to 95% organic for 15 
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minutes at 20 µL/min to flush the loop. After this flushing period, at time 15.1 Valve 2 is set to on, at 
15.2 Valve 3 is set to off, at 15.3 Valve 4 is set to off, and at 15.4 Valve 1 is set to on. This pushes solvent 
through the long axial column. The method file should be set to end after 4 hours. The file can be used 
consecutively in order to achieve flushing overnight. After column flushing, the column should be re-
equilibrated before data acquisition. 
A1.3.5 Sample Acquisition 
 As shown in Figure A-6, and more closely in Figure A-7, a single injection is split into four 
different sample lines within the MassLynx sample queue. This style of setup has the benefit of directly 
controlling gradient loop contents, sample injection, gradient formation, and data collection. 
Additionally, this separation of sample acquisition events allows the software to avoid file sizes which 
are too big for data analysis. 
A1.3.6 Gradient Loop Flushing 
 The first file line corresponds to gradient loop flushing and can be used as an optional command 
line. The method and valve controls, which can be seen in Figures 8 and 9, follow from the column 
flushing for new column use and are as follows. Initial valve states should be Valve 1 off, Valve 2 on, 
Valve 3 on, and Valve 4 on. At time 0.1, Valve 2 is set to off. The inlet method should be set to 20 µL/min 
of 97% A for 18 minutes followed by 0.01 µL/min at time 18.1 minutes. At 18 minutes, Valve 2 should be 
set to on. 
 This method can be altered for column equilibration as follows. Initial valve conditions remain 
the same. At time 0.1 Valve 2 is set to off. The inlet method should be set to 20 µl/min of 97% A for 5 
minutes followed by 0.1 µl/min at time 5.1 minutes. At this point, valves should be changed to Valve 2 
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on at 5.1, Valve 3 off at 5.2, Valve 4 off at 5.3, and Valve 1 on at 5.4. Valve 1 should be set to off at 19.9 
minutes and the method file should end at 20 minutes. 
A1.3.7 Gradient Formation 
 Parallel to conventional chromatography where practical gradient elution is considered in 
percent organic modifier change per minute, for a constant pressure set up where flow rate is variable, 
the gradient program is considered in percent organic modifier change per column volume. The analyst 
should aim for a 2% change in modifier per column volume. For a meter long column packed with 1.9 
µm particles, this equates to an approximate 60 µL gradient. For illustration purposes and to access 
system suitability, an ambitious 12 µL gradient is shown in Figures 10 and 11 as an example. By changing 
the time it takes to reach 4% organic modifier on row 6 of the inlet method file, the analyst can change 
the size of the gradient accordingly with a 0.1 min change providing a one µL change in gradient size. It 
should be noted that all lines proceeding row 6 and method endpoints should be changed accordingly in 
parallel with corresponding valve states. 
 The method file shown in Figure A-10 shows the mobile phase composition and corresponding 
flow rates. It should be noted that the gradient is loaded before the sample and in an opposite order as 
during XUPLC operation, components are played back in reverse. All flow rates for gradient loading are 
done at 10 µL/min and follow curve 6 (linear solvent change during the time interval). Mobile phase 
composition is set to 4% B initially changing to 85% B at 1.1 min till 1.3 min, 40% B at 1.4 min, and 4% at 
2.6 min till 3 min. Corresponding valves states, seen in Figure A-11, are Valve 1 off, Valve 2 on, Valve 3 
on, and Valve 4 on initially, which changes to Valve 2 to off at 0.01 min, Valve 3 off at 3.0 min, and Valve 
2 on at 3.0 min. 
A1.3.8 Sample Loading 
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 The instrument method for sample loading follows instructions similar to gradient loading. 
Important primarily to sample loading is the sample plug must be pushed past the column Valco T in 
order for it to be pushed onto the column during Haskell pump operation. The sample plug is pushed 
with starting condition mobile phase composed of 4% B. The method file shown in Figures 12 and 13 
pushes the sample with 19 µL of mobile phase. While this volume of push solvent has been shown to 
produce acceptable results, it is not optimized. Optimizing the plug size used can be accomplished by 
decreasing the push time to shorter than 1.9 min, continuing with data collection, and measuring peak 
areas to determine if sample has been lost due to insufficient push volume. Future optimization of 
sample push time will result in significant time savings. 
 As shown in Figure A-12, sample loading is accomplished by simply making an injection (as 
indicated in the auto-sample page) and pushing the injection plug for 1.9 minutes at 10 µL/min. 
Subsequent to pushing the sample plug, the flow rate is set to 0. Meanwhile, shown in Figure A-13, 
valves states are altered to begin chromatographic sample separation. Initial valve states are Valve 1 off, 
Valve 2 off, Valve 3 on, and Valve 4 on. At min 2.2, Valve 2 is set to on and Valve 3 begins a toggling 
event. A toggling event has been programmed into the method sequence to prevent the valve from 
sticking immediately prior to high pressure use. The toggle event consists of a rapid on-off valve 
switching every 0.05 min for 0.25 minutes. After the toggling event, Valve 3 is off, Valve 2 is on, Valve 4 
is off, and Valve 1 is set to on. 
A1.3.9 Data Acquisition 
 The fourth and final row in the sample queue corresponds to the data file and should be named 
appropriately (Figures 14 and 15). Valve states follow from row three in the queue and should be 
initially set at Valves 3 and 4 off with Valves 1 and 2 on. Upon completion of data collection, typically 
120 minutes for a one meter column, Valves 1 and 4 are set to off and on respectively to end 
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chromatographic development. The Inlet method file has the flow rate set to 0.01 for the course of the 
run and should be set to end at 120 minutes. MS data acquisition file should be set according to needs. 
A typical MS method used is an MSe data acquisition with a collision energy ramp from 15 to 40 V set to 
record at the expected time of peptide elution. 
A1.4 Preliminary XUPLC Results 
 Figure A-16 shows preliminary results which can be expected when utilizing a 100 cm long 
column. The chromatogram on the top shows a BSA digest standard on a Waters 10 cm 1.7 µm BEH 
nanoACQUITY column. The bottom chromatogram shows the same BSA digest when developed through 
a 100 cm column packed with the same Waters 1.7 µm BEH material. The results produced follow from 
theory and are as expected.  
With utilization of the longer column, there is higher resolution observed between two identical 
sets of peptides. Resolution is defined by equation (4) where tr is retention time and W is peak width. 
 
   
  (  )  (  )  
     
 
(4) 
Using resolution as a means to evaluate column performance, we see the 10 cm commercial column 
producing a resolution of 0.72 for the two peptides with the 100 cm column producing a resolution of 
2.5. As a resolution of 1.5 is considered baseline resolution, this gain in separation efficiency is quite 
substantial.  
It should be noted that there is a general difference between the two chromatograms in that 
different peaks are seen. More specifically, both chromatograms fail to show the 39 expected peptides 
which should be present in a BSA digest with the top chromatogram showing approximately 29 separate 
peaks and the bottom chromatogram showing approximately 26 separate peaks. Furthermore, 
evaluation of ion intensities between the two chromatograms show a greater than 10-fold decrease in 
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sensitivity from the top chromatogram to the bottom. This loss of sensitivity was not a consequence of 
the XUPLC operation. To the contrary, the lower flow rates associated with XUPLC operation should 
result in a gain of sensitivity. It was discovered over the implementation of the XUPLC that there were 
several issues with Mass Spec Laboratory nanoACQUITY instrument as regards cleanliness, maintenance 
habits, and a lack of operation checks to serve as instrumentation readiness criteria. In addition, the 
detector plate on the Synapt G2 was in the process of lifetime failure, to the point that replacement was 
required. Despite the promising gains in resolution through an increase in chromatographic space, the 
considerable effort put forth to reach acceptable operational status when moving to the XUPLC, the 
existing problems with instrumentation prevented further evaluation of the extended chromatographic 
system. As a result further efforts to implement the XUPLC system has been placed on hold until new 
instrumentation can be acquired to avoid the issues noted.  
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A1.5 Appendix Figures 
 
 
Figure A-1. Custom high-pressure fittings obtained from the University of North Carolina, with Waters approval, next to 
fused-silica capillary and a ruler for scale. The front ferrule is a Valco high pressure PEEK ferrule which is drilled out to 380 ID 
prior to use. The connecting nut, back ferrule, and backing nut are custom made. A PEEK sleeve is also used with this 
connection scheme (not shown). 
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Figure A-2. Packing station set-up showing a Haskel DSF-100 connected to a  Haskel RDSXHF-903. Solvent reservoirs are seen 
above. The Haskel 903 outlet is connected to the packing bomb (Figure A-3). 
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Figure A-3. Packing bomb. Internal volume is approximately 400 µL. The inlet is attached to the Haskel 903 and the outlet can 
be seen connected to fused-silica capillary for packing. 
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Figure A-4. XUPLC system design featuring connection points between the nanoACQUITY and Synapt G2.  
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Figure A-5. XUPLC system shown in the KU mass spectrometry laboratory. Haskell 903 can be viewed on the bottom right. To 
right of the nanoACQUITY is a custom made bench, with pin valves attached, to hold the column heater. 
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Figure A-6. Screenshot of a typical sample list featuring XUPLC samples. Each individual run is comprised of four to five lines 
in the sample queue to control gradient formation, sample loading, and file sizes for data acquisition. 
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Figure A-7. Expected sample queue information for a single XUPLC injection featuring column equilibration, gradient loading, 
sample loading, and data acquisition. 
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Figure A-8. Inlet method for loop flushing. 
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Figure A-9. Sample Manager Events for loop flushing. 
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Figure A-10. Inlet method for a 12 µL gradient.  
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Figure A-11. Sample manager events for gradient loading. 
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Figure A-12. Inlet method for sample loading with a 19 µL injection push.  
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Figure A-13. Sample Manager events for sample loading featuring valve toggling between minute 2.5 and minute 3 and 
Haskel 903 activation at minute 4.  
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Figure A-14. Inlet method for data acquisition. 
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Figure A-15. Sample Manager events for data acquisition featuring Haskel 903 deactivation. 
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Figure A-16. Comparison of (top) commercial ACQUITY BEH 1.7 µm 10 cm x 75 µm column with a (bottom) custom packed 
ACQUITY BEH 1.7 µm particles in a 100 cm x 75 µm column. Highlighted areas show identical peptides with a gain in 
resolution from 0.72 to 2.5 when moving from the 10 cm column to the 100 cm column respectively. 
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